Symbol:
SMPD3
Name:
sphingomyelin phosphodiesterase 3
RGD ID:
1347416
HGNC Page
HGNC:14240
Description:
Enables sphingomyelin phosphodiesterase activity. Involved in sphingomyelin catabolic process. Predicted to be located in plasma membrane. Predicted to be active in cytoplasm. Biomarker of pulmonary emphysema.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
FLJ22593; MGC138443; neutral sphingomyelinase 2; neutral sphingomyelinase II; nSMase-2; NSMASE2; sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Smpd3 (sphingomyelin phosphodiesterase 3, neutral)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Smpd3 (sphingomyelin phosphodiesterase 3)
HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther
Chinchilla lanigera (long-tailed chinchilla):
Smpd3 (sphingomyelin phosphodiesterase 3)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
SMPD3 (sphingomyelin phosphodiesterase 3)
NCBI
Ortholog
Canis lupus familiaris (dog):
SMPD3 (sphingomyelin phosphodiesterase 3)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Smpd3 (sphingomyelin phosphodiesterase 3)
NCBI
Ortholog
Sus scrofa (pig):
SMPD3 (sphingomyelin phosphodiesterase 3)
HGNC
EggNOG, Ensembl, NCBI, OMA, OrthoDB, Panther, Treefam
Chlorocebus sabaeus (green monkey):
SMPD3 (sphingomyelin phosphodiesterase 3)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Smpd3 (sphingomyelin phosphodiesterase 3)
NCBI
Ortholog
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Smpd3 (sphingomyelin phosphodiesterase 3)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Smpd3 (sphingomyelin phosphodiesterase 3, neutral)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
smpd3 (sphingomyelin phosphodiesterase 3, neutral)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid|ZFIN)
Xenopus tropicalis (tropical clawed frog):
smpd3
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB)
Xenopus laevis (African clawed frog):
smpd3.L
Alliance
DIOPT (Xenbase)
Xenopus laevis (African clawed frog):
smpd3.S
Alliance
DIOPT (Xenbase)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 16 68,358,327 - 68,448,508 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 16 68,358,327 - 68,448,508 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 16 68,392,230 - 68,482,411 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 16 66,949,731 - 67,039,905 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 16 66,949,732 - 67,039,905 NCBI Celera 16 52,900,779 - 52,990,952 (-) NCBI Celera Cytogenetic Map 16 q22.1 NCBI HuRef 16 54,265,453 - 54,355,875 (-) NCBI HuRef CHM1_1 16 69,800,294 - 69,890,458 (-) NCBI CHM1_1 T2T-CHM13v2.0 16 74,154,167 - 74,244,330 (-) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
SMPD3 Human (+)-schisandrin B multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMPD3 mRNA] CTD PMID:31150632 SMPD3 Human (1->4)-beta-D-glucan multiple interactions ISO Smpd3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SMPD3 mRNA CTD PMID:36331819 SMPD3 Human (S)-nicotine multiple interactions ISO Smpd3 (Mus musculus) 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 SMPD3 Human 1,2-dimethylhydrazine multiple interactions ISO Smpd3 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMPD3 mRNA CTD PMID:22206623 SMPD3 Human 1,2-dimethylhydrazine affects expression ISO Smpd3 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of SMPD3 mRNA CTD PMID:22206623 SMPD3 Human 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression ISO Smpd3 (Rattus norvegicus) 6480464 chlorcyclizine results in increased expression of SMPD3 mRNA CTD PMID:21058326 SMPD3 Human 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO Smpd3 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 SMPD3 Human 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO Smpd3 (Mus musculus) 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 SMPD3 Human 1-naphthyl isothiocyanate increases expression ISO Smpd3 (Mus musculus) 6480464 1-Naphthylisothiocyanate results in increased expression of SMPD3 mRNA CTD PMID:27853831 and PMID:29737914 SMPD3 Human 17alpha-ethynylestradiol affects expression ISO Smpd3 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of SMPD3 mRNA CTD PMID:17555576 SMPD3 Human 17alpha-ethynylestradiol increases expression ISO Smpd3 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of SMPD3 mRNA CTD PMID:17557909 SMPD3 Human 17beta-estradiol multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of SMPD3 mRNA CTD PMID:26496021 SMPD3 Human 17beta-estradiol increases expression ISO Smpd3 (Mus musculus) 6480464 Estradiol results in increased expression of SMPD3 mRNA CTD PMID:39298647 SMPD3 Human 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO Smpd3 (Mus musculus) 6480464 2 more ... CTD PMID:20005886 SMPD3 Human 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:34627992 SMPD3 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Smpd3 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 SMPD3 Human 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Smpd3 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 SMPD3 Human 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Smpd3 (Mus musculus) 6480464 [Flame Retardants results in increased abundance of 2 more ... CTD PMID:38995820 SMPD3 Human 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Smpd3 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 SMPD3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Smpd3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SMPD3 mRNA CTD PMID:20005886 SMPD3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SMPD3 mRNA CTD PMID:23152189 SMPD3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Smpd3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SMPD3 mRNA CTD PMID:21570461 SMPD3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SMPD3 mRNA CTD PMID:21215274 and PMID:21964420 SMPD3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Smpd3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of SMPD3 mRNA CTD PMID:22298810 SMPD3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Smpd3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SMPD3 mRNA CTD PMID:19933214 SMPD3 Human 2,3,7,8-Tetrachlorodibenzofuran multiple interactions ISO Smpd3 (Mus musculus) 6480464 AHR gene mutant form inhibits the reaction [2 more ... CTD PMID:34097992 SMPD3 Human 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Smpd3 (Mus musculus) 6480464 2 more ... CTD PMID:34097992 SMPD3 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Smpd3 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 SMPD3 Human 2,4-dinitrotoluene affects expression ISO Smpd3 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of SMPD3 mRNA CTD PMID:21346803 SMPD3 Human 2-amino-2-deoxy-D-glucopyranose decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of SMPD3 mRNA CTD PMID:17109745 SMPD3 Human 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of SMPD3 mRNA CTD PMID:30851411 SMPD3 Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 SMPD3 Human 3,4-dichloroaniline increases expression ISO Smpd3 (Rattus norvegicus) 6480464 3 and 4-dichloroaniline results in increased expression of SMPD3 mRNA CTD PMID:24172598 SMPD3 Human 4,4'-sulfonyldiphenol increases expression ISO Smpd3 (Mus musculus) 6480464 bisphenol S results in increased expression of SMPD3 mRNA CTD PMID:39298647 SMPD3 Human 4,4'-sulfonyldiphenol increases methylation ISO Smpd3 (Mus musculus) 6480464 bisphenol S results in increased methylation of SMPD3 exon and bisphenol S results in increased methylation of SMPD3 promoter CTD PMID:33297965 SMPD3 Human 4-hydroxyphenyl retinamide decreases expression ISO Smpd3 (Mus musculus) 6480464 Fenretinide results in decreased expression of SMPD3 mRNA CTD PMID:28973697 SMPD3 Human 5-aza-2'-deoxycytidine multiple interactions ISO Smpd3 (Mus musculus) 6480464 [[Decitabine co-treated with trichostatin A] affects the methylation of SMPD3 promoter] which affects the expression of SMPD3 mRNA CTD PMID:18836996 SMPD3 Human 6-propyl-2-thiouracil increases expression ISO Smpd3 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of SMPD3 mRNA CTD PMID:24780913 SMPD3 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SMPD3 mRNA CTD PMID:32234424 and PMID:35690182 SMPD3 Human Aflatoxin B2 alpha decreases methylation EXP 6480464 aflatoxin B2 results in decreased methylation of SMPD3 intron CTD PMID:30157460 SMPD3 Human aldehydo-D-glucosamine decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of SMPD3 mRNA CTD PMID:17109745 SMPD3 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of SMPD3 mRNA CTD PMID:23724009 SMPD3 Human alpha-Zearalanol multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SMPD3 mRNA CTD PMID:35163327 SMPD3 Human Ampullosporin multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 [ampullosporin co-treated with Ketamine] results in decreased expression of SMPD3 mRNA CTD PMID:16635253 SMPD3 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of SMPD3 mRNA CTD PMID:33212167 SMPD3 Human arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SMPD3 mRNA CTD PMID:32525701 SMPD3 Human arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SMPD3 mRNA CTD PMID:32525701 SMPD3 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of SMPD3 mRNA CTD PMID:20458559 SMPD3 Human atrazine decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Atrazine results in decreased expression of SMPD3 mRNA CTD PMID:36841081 SMPD3 Human benzo[a]pyrene increases expression ISO Smpd3 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SMPD3 mRNA CTD PMID:32417428 SMPD3 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SMPD3 mRNA CTD PMID:32234424 and PMID:35690182 SMPD3 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of SMPD3 promoter CTD PMID:27901495 SMPD3 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of SMPD3 5' UTR CTD PMID:27901495 SMPD3 Human benzo[e]pyrene decreases methylation EXP 6480464 benzo(e)pyrene results in decreased methylation of SMPD3 intron CTD PMID:30157460 SMPD3 Human Benzo[k]fluoranthene increases expression ISO Smpd3 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of SMPD3 mRNA CTD PMID:26377693 SMPD3 Human beta-D-glucosamine decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of SMPD3 mRNA CTD PMID:17109745 SMPD3 Human bis(2-ethylhexyl) phthalate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SMPD3 mRNA CTD PMID:39150890 SMPD3 Human bisphenol A multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of SMPD3 mRNA CTD PMID:26496021 SMPD3 Human bisphenol A increases expression ISO Smpd3 (Mus musculus) 6480464 bisphenol A results in increased expression of SMPD3 mRNA CTD PMID:32156529 SMPD3 Human bisphenol A decreases expression ISO Smpd3 (Mus musculus) 6480464 bisphenol A results in decreased expression of SMPD3 mRNA CTD PMID:33221593 SMPD3 Human bisphenol A decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of SMPD3 mRNA CTD PMID:25181051 SMPD3 Human Butylbenzyl phthalate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SMPD3 mRNA CTD PMID:39150890 SMPD3 Human cadmium atom decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Cadmium results in decreased expression of SMPD3 mRNA CTD PMID:39025289 SMPD3 Human caffeine multiple interactions ISO Smpd3 (Mus musculus) 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 SMPD3 Human camptothecin increases expression EXP 6480464 Camptothecin results in increased expression of SMPD3 mRNA CTD PMID:19698806 SMPD3 Human carbon nanotube increases expression ISO Smpd3 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 SMPD3 Human cholesterol multiple interactions ISO Smpd3 (Mus musculus) 6480464 [Cholesterol co-treated with 1 and 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of SMPD3 mRNA CTD PMID:22129739 SMPD3 Human choline multiple interactions ISO Smpd3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SMPD3 mRNA CTD PMID:20938992 SMPD3 Human chrysene increases expression ISO Smpd3 (Mus musculus) 6480464 chrysene results in increased expression of SMPD3 mRNA CTD PMID:26377693 SMPD3 Human clothianidin decreases expression EXP 6480464 clothianidin results in decreased expression of SMPD3 mRNA CTD PMID:35690182 SMPD3 Human copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of SMPD3 mRNA CTD PMID:19549813 SMPD3 Human cyproconazole increases expression ISO Smpd3 (Mus musculus) 6480464 cyproconazole results in increased expression of SMPD3 mRNA CTD PMID:22334560 SMPD3 Human daunorubicin increases expression EXP 6480464 Daunorubicin results in increased expression of SMPD3 mRNA and Daunorubicin results in increased expression of SMPD3 protein CTD PMID:19698806 SMPD3 Human daunorubicin increases response to substance EXP 6480464 SMPD3 results in increased susceptibility to Daunorubicin CTD PMID:19698806 SMPD3 Human dextran sulfate increases expression ISO Smpd3 (Mus musculus) 6480464 Dextran Sulfate results in increased expression of SMPD3 protein CTD PMID:35362542 SMPD3 Human dextran sulfate multiple interactions ISO Smpd3 (Mus musculus) 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMPD3 protein] CTD PMID:35362542 SMPD3 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of SMPD3 mRNA CTD PMID:20458559 SMPD3 Human diazinon affects expression ISO Smpd3 (Rattus norvegicus) 6480464 Diazinon affects the expression of SMPD3 mRNA CTD PMID:22546817 SMPD3 Human dibutyl phthalate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SMPD3 mRNA CTD PMID:39150890 SMPD3 Human dichloroacetic acid increases expression ISO Smpd3 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of SMPD3 mRNA CTD PMID:28962523 SMPD3 Human dieldrin affects expression ISO Smpd3 (Rattus norvegicus) 6480464 Dieldrin affects the expression of SMPD3 mRNA CTD PMID:22546817 SMPD3 Human diethyl phthalate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SMPD3 mRNA CTD PMID:39150890 SMPD3 Human diisobutyl phthalate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SMPD3 mRNA CTD PMID:39150890 SMPD3 Human diisononyl phthalate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SMPD3 mRNA CTD PMID:39150890 SMPD3 Human diuron decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Diuron results in decreased expression of SMPD3 mRNA CTD PMID:25152437 SMPD3 Human diuron increases expression ISO Smpd3 (Rattus norvegicus) 6480464 Diuron metabolite results in increased expression of SMPD3 mRNA CTD PMID:24172598 SMPD3 Human endosulfan decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of SMPD3 mRNA CTD PMID:29391264 SMPD3 Human epoxiconazole increases expression ISO Smpd3 (Mus musculus) 6480464 epoxiconazole results in increased expression of SMPD3 mRNA CTD PMID:22334560 and PMID:23970803 SMPD3 Human ethanol increases expression ISO Smpd3 (Mus musculus) 6480464 Ethanol results in increased expression of SMPD3 mRNA CTD PMID:30319688 SMPD3 Human ethanol decreases expression ISO Smpd3 (Mus musculus) 6480464 Ethanol results in decreased expression of SMPD3 mRNA CTD PMID:34755883 SMPD3 Human Evodiamine multiple interactions ISO Smpd3 (Mus musculus) 6480464 evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMPD3 protein] CTD PMID:35362542 SMPD3 Human fenamidone decreases expression ISO Smpd3 (Mus musculus) 6480464 fenamidone results in decreased expression of SMPD3 mRNA CTD PMID:27029645 SMPD3 Human fenofibrate increases expression ISO Smpd3 (Mus musculus) 6480464 Fenofibrate results in increased expression of SMPD3 mRNA CTD PMID:21318169 SMPD3 Human fenofibrate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of SMPD3 mRNA CTD PMID:21318169 SMPD3 Human fipronil increases expression ISO Smpd3 (Rattus norvegicus) 6480464 fipronil results in increased expression of SMPD3 mRNA CTD PMID:31881178 SMPD3 Human flavonoids increases expression ISO Smpd3 (Rattus norvegicus) 6480464 Flavonoids results in increased expression of SMPD3 mRNA CTD PMID:18035473 SMPD3 Human folic acid multiple interactions ISO Smpd3 (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 SMPD3 Human fumonisin B1 multiple interactions ISO Smpd3 (Mus musculus) 6480464 [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA and [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of SMPD3 mRNA CTD PMID:30448865 SMPD3 Human furan decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 furan results in decreased expression of SMPD3 mRNA CTD PMID:26194646 SMPD3 Human GW 4064 multiple interactions ISO Smpd3 (Mus musculus) 6480464 GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SMPD3 mRNA] CTD PMID:28223344 SMPD3 Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of SMPD3 mRNA CTD PMID:20044591 SMPD3 Human hydrogen peroxide increases activity EXP 6480464 Hydrogen Peroxide results in increased activity of SMPD3 protein CTD PMID:17498692 SMPD3 Human Indeno[1,2,3-cd]pyrene decreases expression ISO Smpd3 (Mus musculus) 6480464 indeno(1 more ... CTD PMID:26377693 SMPD3 Human ketamine multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 [ampullosporin co-treated with Ketamine] results in decreased expression of SMPD3 mRNA CTD PMID:16635253 SMPD3 Human L-methionine multiple interactions ISO Smpd3 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SMPD3 mRNA CTD PMID:20938992 SMPD3 Human Lasiocarpine decreases expression EXP 6480464 lasiocarpine results in decreased expression of SMPD3 mRNA CTD PMID:32234424 and PMID:35690182 SMPD3 Human lipopolysaccharide multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SMPD3 mRNA CTD PMID:35811015 SMPD3 Human lithocholic acid increases expression ISO Smpd3 (Mus musculus) 6480464 Lithocholic Acid results in increased expression of SMPD3 mRNA CTD PMID:21480330 SMPD3 Human magnesium dichloride multiple interactions ISO Smpd3 (Mus musculus) 6480464 [Magnesium Chloride co-treated with Phosphatidylserines] promotes the reaction [SMPD3 protein results in increased degradation of Sphingomyelins] CTD PMID:12566438 SMPD3 Human methapyrilene decreases methylation EXP 6480464 Methapyrilene results in decreased methylation of SMPD3 intron CTD PMID:30157460 SMPD3 Human methotrexate affects expression ISO Smpd3 (Mus musculus) 6480464 Methotrexate affects the expression of SMPD3 mRNA CTD PMID:18502557 SMPD3 Human N-nitrosodiethylamine increases expression ISO Smpd3 (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of SMPD3 mRNA CTD PMID:20387270 SMPD3 Human N-nitrosodiethylamine increases expression ISO Smpd3 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of SMPD3 mRNA CTD PMID:24535843 SMPD3 Human N-Nitrosopyrrolidine decreases expression EXP 6480464 N-Nitrosopyrrolidine results in decreased expression of SMPD3 mRNA CTD PMID:32234424 and PMID:35690182 SMPD3 Human nickel dichloride affects expression ISO Smpd3 (Rattus norvegicus) 6480464 nickel chloride affects the expression of SMPD3 mRNA CTD PMID:22546817 SMPD3 Human nicotine multiple interactions ISO Smpd3 (Mus musculus) 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 SMPD3 Human O-methyleugenol decreases expression EXP 6480464 methyleugenol results in decreased expression of SMPD3 mRNA CTD PMID:32234424 and PMID:35690182 SMPD3 Human Octicizer multiple interactions ISO Smpd3 (Mus musculus) 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1 and 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of SMPD3 mRNA CTD PMID:33367866 SMPD3 Human oxaliplatin multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SMPD3 mRNA CTD PMID:25729387 SMPD3 Human oxaliplatin increases expression ISO Smpd3 (Rattus norvegicus) 6480464 oxaliplatin results in increased expression of SMPD3 mRNA CTD PMID:25729387 SMPD3 Human ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of SMPD3 mRNA CTD PMID:35430440 SMPD3 Human p-toluidine decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 4-toluidine results in decreased expression of SMPD3 mRNA CTD PMID:27638505 SMPD3 Human paracetamol affects expression ISO Smpd3 (Mus musculus) 6480464 Acetaminophen affects the expression of SMPD3 mRNA CTD PMID:17562736 SMPD3 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SMPD3 mRNA CTD PMID:26690555 SMPD3 Human paraquat increases expression ISO Smpd3 (Rattus norvegicus) 6480464 Paraquat results in increased expression of SMPD3 mRNA CTD PMID:32680482 SMPD3 Human PCB138 multiple interactions ISO Smpd3 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 SMPD3 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Smpd3 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SMPD3 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SMPD3 mRNA CTD PMID:36331819 SMPD3 Human perfluorooctanoic acid increases expression ISO Smpd3 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of SMPD3 mRNA CTD PMID:35163327 SMPD3 Human perfluorooctanoic acid multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SMPD3 mRNA CTD PMID:35163327 SMPD3 Human phenethyl caffeate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of SMPD3 mRNA more ... CTD PMID:28223344 SMPD3 Human phenobarbital increases expression ISO Smpd3 (Mus musculus) 6480464 Phenobarbital results in increased expression of SMPD3 mRNA CTD PMID:19482888 and PMID:23091169 SMPD3 Human pirinixic acid multiple interactions ISO Smpd3 (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in decreased expression of SMPD3 mRNA] CTD PMID:21318169 SMPD3 Human pirinixic acid increases expression ISO Smpd3 (Mus musculus) 6480464 pirinixic acid results in increased expression of SMPD3 mRNA CTD PMID:23811191 SMPD3 Human pirinixic acid decreases expression ISO Smpd3 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SMPD3 mRNA CTD PMID:17426115 more ... SMPD3 Human propanal decreases expression EXP 6480464 propionaldehyde results in decreased expression of SMPD3 mRNA CTD PMID:26079696 SMPD3 Human propiconazole increases expression ISO Smpd3 (Mus musculus) 6480464 propiconazole results in increased expression of SMPD3 mRNA CTD PMID:21278054 more ... SMPD3 Human rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of SMPD3 mRNA CTD PMID:30851411 SMPD3 Human S-(1,2-dichlorovinyl)-L-cysteine increases expression EXP 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of SMPD3 mRNA CTD PMID:35811015 SMPD3 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SMPD3 mRNA CTD PMID:35811015 SMPD3 Human sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SMPD3 mRNA CTD PMID:32525701 SMPD3 Human sodium arsenate decreases expression ISO Smpd3 (Mus musculus) 6480464 sodium arsenate results in decreased expression of SMPD3 mRNA CTD PMID:21795629 SMPD3 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SMPD3 mRNA CTD PMID:29301061 and PMID:34032870 SMPD3 Human sodium arsenite decreases expression ISO Smpd3 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SMPD3 mRNA CTD PMID:33933676 and PMID:37682722 SMPD3 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of SMPD3 mRNA CTD PMID:38568856 SMPD3 Human sodium dichromate decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 sodium bichromate results in decreased expression of SMPD3 mRNA CTD PMID:25993096 SMPD3 Human sotorasib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SMPD3 mRNA CTD PMID:36139627 SMPD3 Human tetrachloromethane decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of SMPD3 mRNA CTD PMID:31150632 SMPD3 Human tetrachloromethane multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMPD3 mRNA] CTD PMID:31150632 SMPD3 Human thapsigargin decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 Thapsigargin results in decreased expression of SMPD3 protein CTD PMID:35544339 SMPD3 Human titanium dioxide increases expression ISO Smpd3 (Mus musculus) 6480464 titanium dioxide results in increased expression of SMPD3 mRNA CTD PMID:23557971 SMPD3 Human topotecan increases expression ISO Smpd3 (Rattus norvegicus) 6480464 Topotecan results in increased expression of SMPD3 mRNA CTD PMID:25729387 SMPD3 Human topotecan multiple interactions ISO Smpd3 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SMPD3 mRNA CTD PMID:25729387 SMPD3 Human trametinib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SMPD3 mRNA CTD PMID:36139627 SMPD3 Human triadimefon increases expression ISO Smpd3 (Mus musculus) 6480464 triadimefon results in increased expression of SMPD3 mRNA CTD PMID:23970803 SMPD3 Human tributyl phosphate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1 and 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of SMPD3 mRNA CTD PMID:33367866 SMPD3 Human trichostatin A multiple interactions ISO Smpd3 (Mus musculus) 6480464 [[decitabine co-treated with trichostatin A] affects the methylation of SMPD3 promoter] which affects the expression of SMPD3 mRNA CTD PMID:18836996 SMPD3 Human triclosan increases expression EXP 6480464 Triclosan results in increased expression of SMPD3 mRNA CTD PMID:30510588 SMPD3 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of SMPD3 mRNA CTD PMID:37042841 SMPD3 Human triphenyl phosphate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1 and 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of SMPD3 mRNA CTD PMID:33367866 SMPD3 Human tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of SMPD3 mRNA CTD PMID:29024780 SMPD3 Human tris(2-butoxyethyl) phosphate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1 and 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of SMPD3 mRNA CTD PMID:33367866 SMPD3 Human tris(2-chloroethyl) phosphate multiple interactions ISO Smpd3 (Mus musculus) 6480464 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1 and 3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of SMPD3 mRNA CTD PMID:33367866 SMPD3 Human undecane decreases expression ISO Smpd3 (Rattus norvegicus) 6480464 undecane results in decreased expression of SMPD3 protein CTD PMID:17337753 SMPD3 Human urethane increases expression EXP 6480464 Urethane results in increased expression of SMPD3 mRNA CTD PMID:28818685 SMPD3 Human valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of SMPD3 gene CTD PMID:29154799
Imported Annotations - KEGG (archival)
Imported Annotations - PID (archival)
(+)-schisandrin B (ISO) (1->4)-beta-D-glucan (ISO) (S)-nicotine (ISO) 1,2-dimethylhydrazine (ISO) 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine (ISO) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (ISO) 1-naphthyl isothiocyanate (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 2,4-dinitrotoluene (ISO) 2-amino-2-deoxy-D-glucopyranose (ISO) 2-hydroxypropanoic acid (EXP) 3,3',4,4',5-pentachlorobiphenyl (ISO) 3,4-dichloroaniline (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 5-aza-2'-deoxycytidine (ISO) 6-propyl-2-thiouracil (ISO) aflatoxin B1 (EXP) Aflatoxin B2 alpha (EXP) aldehydo-D-glucosamine (ISO) all-trans-retinoic acid (EXP) alpha-Zearalanol (ISO) Ampullosporin (ISO) aristolochic acid A (EXP) arsane (EXP) arsenic atom (EXP) arsenous acid (EXP) atrazine (ISO) benzo[a]pyrene (EXP,ISO) benzo[e]pyrene (EXP) Benzo[k]fluoranthene (ISO) beta-D-glucosamine (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (ISO) Butylbenzyl phthalate (ISO) cadmium atom (ISO) caffeine (ISO) camptothecin (EXP) carbon nanotube (ISO) cholesterol (ISO) choline (ISO) chrysene (ISO) clothianidin (EXP) copper(II) sulfate (EXP) cyproconazole (ISO) daunorubicin (EXP) dextran sulfate (ISO) diarsenic trioxide (EXP) diazinon (ISO) dibutyl phthalate (ISO) dichloroacetic acid (ISO) dieldrin (ISO) diethyl phthalate (ISO) diisobutyl phthalate (ISO) diisononyl phthalate (ISO) diuron (ISO) endosulfan (ISO) epoxiconazole (ISO) ethanol (ISO) Evodiamine (ISO) fenamidone (ISO) fenofibrate (ISO) fipronil (ISO) flavonoids (ISO) folic acid (ISO) fumonisin B1 (ISO) furan (ISO) GW 4064 (ISO) hydrogen peroxide (EXP) Indeno[1,2,3-cd]pyrene (ISO) ketamine (ISO) L-methionine (ISO) Lasiocarpine (EXP) lipopolysaccharide (EXP) lithocholic acid (ISO) magnesium dichloride (ISO) methapyrilene (EXP) methotrexate (ISO) N-nitrosodiethylamine (ISO) N-Nitrosopyrrolidine (EXP) nickel dichloride (ISO) nicotine (ISO) O-methyleugenol (EXP) Octicizer (ISO) oxaliplatin (ISO) ozone (EXP) p-toluidine (ISO) paracetamol (EXP,ISO) paraquat (ISO) PCB138 (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (ISO) phenethyl caffeate (ISO) phenobarbital (ISO) pirinixic acid (ISO) propanal (EXP) propiconazole (ISO) rac-lactic acid (EXP) S-(1,2-dichlorovinyl)-L-cysteine (EXP) sodium arsenate (EXP,ISO) sodium arsenite (EXP,ISO) sodium dichromate (ISO) sotorasib (EXP) tetrachloromethane (ISO) thapsigargin (ISO) titanium dioxide (ISO) topotecan (ISO) trametinib (EXP) triadimefon (ISO) tributyl phosphate (ISO) trichostatin A (ISO) triclosan (EXP) triphenyl phosphate (EXP,ISO) tris(2-butoxyethyl) phosphate (EXP,ISO) tris(2-chloroethyl) phosphate (ISO) undecane (ISO) urethane (EXP) valproic acid (EXP)
SMPD3 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 16 68,358,327 - 68,448,508 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 16 68,358,327 - 68,448,508 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 16 68,392,230 - 68,482,411 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 16 66,949,731 - 67,039,905 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 16 66,949,732 - 67,039,905 NCBI Celera 16 52,900,779 - 52,990,952 (-) NCBI Celera Cytogenetic Map 16 q22.1 NCBI HuRef 16 54,265,453 - 54,355,875 (-) NCBI HuRef CHM1_1 16 69,800,294 - 69,890,458 (-) NCBI CHM1_1 T2T-CHM13v2.0 16 74,154,167 - 74,244,330 (-) NCBI T2T-CHM13v2.0
Smpd3 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 8 106,979,180 - 107,064,597 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 8 106,979,180 - 107,064,620 (-) Ensembl GRCm39 Ensembl GRCm38 8 106,252,548 - 106,337,965 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 8 106,252,548 - 106,337,988 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 8 108,776,448 - 108,861,888 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 8 109,141,677 - 109,227,117 (-) NCBI MGSCv36 mm8 Celera 8 110,480,448 - 110,565,952 (-) NCBI Celera Cytogenetic Map 8 D3 NCBI cM Map 8 53.12 NCBI
Smpd3 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 19 51,072,209 - 51,155,639 (-) NCBI GRCr8 mRatBN7.2 19 34,162,337 - 34,245,786 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 19 34,162,341 - 34,245,749 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 19 40,977,903 - 41,061,312 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 19 41,631,214 - 41,714,614 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 19 43,930,363 - 44,013,762 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 19 38,237,963 - 38,321,572 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 19 38,237,965 - 38,321,528 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 19 49,107,658 - 49,191,221 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 19 36,112,166 - 36,195,564 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 19 36,117,046 - 36,200,445 (-) NCBI Celera 19 33,589,416 - 33,672,639 (-) NCBI Celera RH 3.4 Map 19 304.3 RGD Cytogenetic Map 19 q12 NCBI
Smpd3 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955484 8,272,572 - 8,298,144 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955484 8,207,686 - 8,298,164 (+) NCBI ChiLan1.0 ChiLan1.0
SMPD3 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 18 77,905,024 - 77,995,458 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 16 83,816,346 - 83,906,775 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 16 48,734,664 - 48,825,241 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 16 68,129,034 - 68,219,625 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 16 68,131,905 - 68,142,871 (-) Ensembl panpan1.1 panPan2
SMPD3 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 5 81,089,657 - 81,172,173 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 5 81,142,888 - 81,172,189 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 5 81,080,156 - 81,162,625 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 5 81,524,565 - 81,607,194 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 5 81,553,588 - 81,606,670 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 5 81,351,425 - 81,433,990 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 5 81,034,510 - 81,116,929 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 5 81,675,446 - 81,757,898 (+) NCBI UU_Cfam_GSD_1.0
Smpd3 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024409349 40,833,996 - 40,920,586 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936475 18,671,428 - 18,755,208 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936475 18,667,563 - 18,755,132 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SMPD3 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 6 28,938,290 - 29,025,357 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 6 28,938,287 - 29,025,397 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 6 26,117,915 - 26,204,889 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SMPD3 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 5 58,965,965 - 59,057,823 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 5 59,029,093 - 59,059,577 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666047 21,702,920 - 21,795,181 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Smpd3 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 5866 Count of miRNA genes: 1199 Interacting mature miRNAs: 1542 Transcripts: ENST00000219334, ENST00000561749, ENST00000563226, ENST00000563396, ENST00000563455, ENST00000566009, ENST00000566466, ENST00000566723, ENST00000567223, ENST00000567811, ENST00000568373, ENST00000574662 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
597123798 GWAS1219872_H chronic obstructive pulmonary disease QTL GWAS1219872 (human) 0.000002 lung integrity trait (VT:0010906) 16 68364972 68364973 Human 596961237 GWAS1080756_H metabolic syndrome QTL GWAS1080756 (human) 3e-09 metabolic syndrome 16 68370063 68370064 Human 597101076 GWAS1197150_H sex hormone-binding globulin measurement QTL GWAS1197150 (human) 7e-12 sex hormone-binding globulin measurement 16 68394941 68394942 Human 597206046 GWAS1302120_H birth weight QTL GWAS1302120 (human) 1e-08 birth weight neonatal body weight (CMO:0002079) 16 68387765 68387766 Human 597336540 GWAS1432614_H COVID-19 QTL GWAS1432614 (human) 0.000004 COVID-19 16 68412307 68412308 Human 597105040 GWAS1201114_H schizophrenia, intelligence, self reported educational attainment QTL GWAS1201114 (human) 6e-11 schizophrenia, intelligence, self reported educational attainment 16 68384889 68384890 Human 597123743 GWAS1219817_H chronic obstructive pulmonary disease QTL GWAS1219817 (human) 0.0000006 lung integrity trait (VT:0010906) 16 68364972 68364973 Human 597394448 GWAS1490522_H metabolic syndrome QTL GWAS1490522 (human) 3e-09 metabolic syndrome 16 68370063 68370064 Human 597280916 GWAS1376990_H sex hormone-binding globulin measurement QTL GWAS1376990 (human) 5e-09 sex hormone-binding globulin measurement 16 68385928 68385929 Human 597328212 GWAS1424286_H Agouti-related protein measurement QTL GWAS1424286 (human) 6e-18 Agouti-related protein measurement 16 68396403 68396404 Human 597189335 GWAS1285409_H sex hormone-binding globulin measurement QTL GWAS1285409 (human) 6e-11 sex hormone-binding globulin measurement 16 68394941 68394942 Human 597120197 GWAS1216271_H chronic obstructive pulmonary disease QTL GWAS1216271 (human) 0.000001 lung integrity trait (VT:0010906) 16 68364972 68364973 Human 597240267 GWAS1336341_H high density lipoprotein cholesterol measurement QTL GWAS1336341 (human) 5e-16 high density lipoprotein cholesterol measurement blood high density lipoprotein cholesterol level (CMO:0000052) 16 68387698 68387699 Human 597241039 GWAS1337113_H high density lipoprotein cholesterol measurement QTL GWAS1337113 (human) 3e-10 high density lipoprotein cholesterol measurement blood apolipoprotein AI level (CMO:0000520) 16 68375260 68375261 Human 597050442 GWAS1146516_H ovarian carcinoma QTL GWAS1146516 (human) 0.000001 ovarian carcinoma 16 68366522 68366523 Human 597287545 GWAS1383619_H body mass index QTL GWAS1383619 (human) 2e-08 body mass index body mass index (BMI) (CMO:0000105) 16 68387873 68387874 Human 597295294 GWAS1391368_H Agouti-related protein measurement QTL GWAS1391368 (human) 7e-11 Agouti-related protein measurement 16 68394186 68394187 Human 597285180 GWAS1381254_H body weight QTL GWAS1381254 (human) 2e-09 body mass (VT:0001259) body weight (CMO:0000012) 16 68374216 68374217 Human 597123952 GWAS1220026_H smoking status measurement, chronic obstructive pulmonary disease QTL GWAS1220026 (human) 4e-09 lung integrity trait (VT:0010906) 16 68364972 68364973 Human 597254526 GWAS1350600_H apolipoprotein A 1 measurement QTL GWAS1350600 (human) 5e-14 apolipoprotein A 1 measurement blood apolipoprotein AI level (CMO:0000520) 16 68387698 68387699 Human 597482614 GWAS1578688_H birth weight, parental genotype effect measurement QTL GWAS1578688 (human) 8e-08 birth weight, parental genotype effect measurement neonatal body weight (CMO:0002079) 16 68365021 68365022 Human 597325236 GWAS1421310_H schizophrenia QTL GWAS1421310 (human) 3e-09 schizophrenia 16 68381072 68381073 Human 597124066 GWAS1220140_H smoking status measurement, chronic obstructive pulmonary disease QTL GWAS1220140 (human) 1e-08 lung integrity trait (VT:0010906) 16 68364972 68364973 Human 597279340 GWAS1375414_H hydroxy-N6,N6,N6-trimethyllysine measurement QTL GWAS1375414 (human) 2e-13 hydroxy-N6,N6,N6-trimethyllysine measurement 16 68387873 68387874 Human 597336812 GWAS1432886_H COVID-19 QTL GWAS1432886 (human) 0.000003 COVID-19 16 68412307 68412308 Human 597048545 GWAS1144619_H ovarian carcinoma QTL GWAS1144619 (human) 0.000003 ovarian carcinoma 16 68366522 68366523 Human 597232161 GWAS1328235_H lipoprotein A measurement QTL GWAS1328235 (human) 3e-12 lipoprotein A measurement 16 68362216 68362217 Human 597483232 GWAS1579306_H birth weight QTL GWAS1579306 (human) 0.000007 birth weight neonatal body weight (CMO:0002079) 16 68365021 68365022 Human 597189604 GWAS1285678_H free androgen index QTL GWAS1285678 (human) 1e-08 free androgen index 16 68394941 68394942 Human 597097771 GWAS1193845_H sex hormone-binding globulin measurement QTL GWAS1193845 (human) 8e-10 sex hormone-binding globulin measurement 16 68394941 68394942 Human 597047595 GWAS1143669_H erythrocyte count QTL GWAS1143669 (human) 9e-09 erythrocyte count red blood cell count (CMO:0000025) 16 68419050 68419051 Human
RH92696
Human Assembly Chr Position (strand) Source JBrowse GRCh37 16 68,394,664 - 68,394,754 UniSTS GRCh37 Build 36 16 66,952,165 - 66,952,255 RGD NCBI36 Celera 16 52,903,212 - 52,903,302 RGD Cytogenetic Map 16 q22.1 UniSTS HuRef 16 54,267,893 - 54,267,983 UniSTS GeneMap99-GB4 RH Map 16 410.38 UniSTS
RH123348
Human Assembly Chr Position (strand) Source JBrowse GRCh37 16 68,431,637 - 68,431,924 UniSTS GRCh37 Build 36 16 66,989,138 - 66,989,425 RGD NCBI36 Celera 16 52,940,180 - 52,940,467 RGD Cytogenetic Map 16 q22.1 UniSTS HuRef 16 54,304,823 - 54,305,110 UniSTS TNG Radiation Hybrid Map 16 29536.0 UniSTS
G59890
Human Assembly Chr Position (strand) Source JBrowse GRCh37 16 68,438,978 - 68,439,099 UniSTS GRCh37 Build 36 16 66,996,479 - 66,996,600 RGD NCBI36 Celera 16 52,947,521 - 52,947,642 RGD Cytogenetic Map 16 q22.1 UniSTS HuRef 16 54,312,164 - 54,312,285 UniSTS TNG Radiation Hybrid Map 16 29539.0 UniSTS
SHGC-61160
Human Assembly Chr Position (strand) Source JBrowse GRCh37 16 68,392,252 - 68,392,440 UniSTS GRCh37 Build 36 16 66,949,753 - 66,949,941 RGD NCBI36 Celera 16 52,900,801 - 52,900,989 RGD Cytogenetic Map 16 q22.1 UniSTS HuRef 16 54,265,475 - 54,265,663 UniSTS GeneMap99-GB4 RH Map 16 406.33 UniSTS NCBI RH Map 16 508.6 UniSTS
RH48608
Human Assembly Chr Position (strand) Source JBrowse GRCh37 16 68,438,978 - 68,439,133 UniSTS GRCh37 Build 36 16 66,996,479 - 66,996,634 RGD NCBI36 Celera 16 52,947,521 - 52,947,676 RGD Cytogenetic Map 16 q22.1 UniSTS HuRef 16 54,312,164 - 54,312,319 UniSTS GeneMap99-GB4 RH Map 16 406.22 UniSTS NCBI RH Map 16 508.6 UniSTS
Smpd3
Human Assembly Chr Position (strand) Source JBrowse GRCh37 16 68,395,182 - 68,395,561 UniSTS GRCh37 Celera 16 52,903,730 - 52,904,109 UniSTS HuRef 16 54,268,411 - 54,268,790 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2431
2788
2242
4921
1720
2337
4
620
1921
462
2251
7242
6425
50
3704
837
1720
1606
170
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000219334 ⟹ ENSP00000219334
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,358,327 - 68,448,508 (-) Ensembl
Ensembl Acc Id:
ENST00000561749 ⟹ ENSP00000457236
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,371,901 - 68,448,492 (-) Ensembl
Ensembl Acc Id:
ENST00000563226 ⟹ ENSP00000455955
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,361,134 - 68,372,258 (-) Ensembl
Ensembl Acc Id:
ENST00000563396
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,361,299 - 68,363,693 (-) Ensembl
Ensembl Acc Id:
ENST00000563455
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,367,452 - 68,371,009 (-) Ensembl
Ensembl Acc Id:
ENST00000566009
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,364,414 - 68,371,031 (-) Ensembl
Ensembl Acc Id:
ENST00000566466
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,368,855 - 68,371,080 (-) Ensembl
Ensembl Acc Id:
ENST00000566723
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,370,974 - 68,448,442 (-) Ensembl
Ensembl Acc Id:
ENST00000567223
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,363,742 - 68,371,031 (-) Ensembl
Ensembl Acc Id:
ENST00000567811
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,364,580 - 68,371,031 (-) Ensembl
Ensembl Acc Id:
ENST00000568373 ⟹ ENSP00000457422
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,361,127 - 68,372,258 (-) Ensembl
Ensembl Acc Id:
ENST00000574662 ⟹ ENSP00000459317
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 16 68,360,538 - 68,371,005 (-) Ensembl
RefSeq Acc Id:
NM_018667 ⟹ NP_061137
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,448,508 (-) NCBI GRCh37 16 68,392,230 - 68,482,409 (-) ENTREZGENE Build 36 16 66,949,731 - 67,039,905 (-) NCBI Archive HuRef 16 54,265,453 - 54,355,875 (-) ENTREZGENE CHM1_1 16 69,800,294 - 69,890,458 (-) NCBI T2T-CHM13v2.0 16 74,154,167 - 74,244,330 (-) NCBI
Sequence:
GTGCTGAGTCTGAGGGAGGCTCCGGACCCGAGAGCCGCGAGAGCCGCCGCCGCTGCGGCCGCCGCCAGATCTGCGGCCGGGAGCCCGGGCTGTGAGGAGCCGGGAGGAGCGGGGTGCGCTGCCGGGCG CTGACCGCCCTCCCGCCCGCCGTCAGAGGTCTGCGGTGACAGCTCTTCTTCAGAGAGAAGGACAACAAGGTCCCAGTGGCCCCTCCTCAGGGTCTGCAGTAGGCCTCCGCATGGCCCACCGAGGTGAA CCATGACCGGCTGGCCAACATTCGCCATTGACCAGCCGGAGTTGCATCTCGCCAGGAGGTGACCCCTCCTCCAGCTGCCCCCAACTCGCCCACCCTCGCCCAGGAAAGTGCCCGCAGCTGCCACGGAC ACCATGTAGTAGGGCCGGCTGCGGCGCCCAGTGAGCTGCGATGGTTTTGTACACGACCCCCTTTCCTAACAGCTGTCTGTCCGCCCTGCACTGTGTGTCCTGGGCCCTTATCTTTCCATGCTACTGGC TGGTGGACCGGCTCGCTGCCTCCTTCATACCCACCACCTACGAGAAGCGCCAGCGGGCAGACGACCCGTGCTGCCTGCAGCTGCTCTGCACTGCCCTCTTCACGCCCATCTACCTGGCCCTCCTGGTG GCCTCGCTGCCCTTTGCGTTTCTCGGCTTTCTCTTCTGGTCCCCACTGCAGTCGGCCCGCCGGCCCTACATCTATTCACGGCTGGAAGACAAGGGCCTGGCCGGTGGGGCAGCCCTGCTCAGTGAATG GAAGGGCACGGGGCCTGGCAAAAGCTTCTGCTTTGCCACTGCCAACGTCTGCCTCCTGCCCGACTCACTCGCCAGGGTCAACAACCTTTTTAACACCCAAGCGCGGGCCAAGGAGATCGGGCAGAGAA TCCGCAATGGGGCCGCCCGGCCCCAGATCAAAATTTACATCGACTCCCCCACCAATACCTCCATCAGCGCCGCTAGCTTCAGCAGCCTGGTGTCACCACAGGGCGGCGATGGGGTGGCCCGGGCCGTC CCCGGGAGCATTAAGAGGACAGCCTCTGTGGAGTACAAGGGTGACGGTGGGCGGCACCCCGGTGACGAGGCTGCCAACGGCCCAGCCTCTGGGGACCCTGTCGACAGCAGCAGCCCGGAGGATGCCTG CATCGTGCGCATCGGTGGCGAGGAGGGCGGCCGGCCACCTGAAGCTGACGACCCTGTGCCTGGGGGCCAGGCCAGGAACGGAGCTGGCGGGGGCCCAAGGGGCCAGACGCCCAACCATAATCAGCAGG ACGGGGATTCAGGGAGCCTGGGCAGCCCCTCGGCCTCCCGGGAGTCCCTGGTGAAGGGGCGAGCTGGGCCAGACACCAGTGCCAGCGGGGAGCCAGGTGCCAACAGCAAGCTCCTGTACAAGGCCTCG GTGGTGAAGAAGGCGGCTGCACGCAGGAGGCGGCACCCCGACGAGGCCTTCGACCATGAGGTCTCCGCCTTCTTCCCCGCCAACCTGGACTTCCTGTGCCTGCAGGAGGTGTTTGACAAGCGAGCAGC CACCAAATTGAAAGAGCAGCTGCACGGCTACTTCGAGTACATCCTGTACGACGTCGGGGTCTACGGCTGCCAGGGCTGCTGCAGCTTCAAGTGTCTCAACAGCGGCCTCCTCTTTGCCAGCCGCTACC CCATCATGGACGTGGCCTATCACTGTTACCCCAACAAGTGTAACGACGATGCCCTGGCCTCTAAGGGAGCTCTGTTTCTCAAGGTGCAGGTGGGAAGCACACCTCAGGACCAAAGAATCGTCGGGTAC ATCGCCTGCACACACCTGCATGCCCCGCAAGAGGACAGCGCCATCCGGTGTGGGCAGCTGGACCTGCTTCAGGACTGGCTGGCTGATTTCCGAAAATCTACCTCCTCGTCCAGCGCAGCCAACCCCGA GGAGCTGGTGGCATTTGACGTCGTCTGTGGAGATTTCAACTTTGATAACTGCTCCTCTGACGACAAGCTGGAGCAGCAACACTCCCTGTTCACCCACTACAGGGACCCCTGCCGCCTGGGGCCTGGTG AGGAGAAGCCGTGGGCCATCGGTACTCTGCTGGACACGAACGGCCTGTACGATGAGGATGTGTGCACCCCCGACAACCTGCAGAAGGTCCTGGAGAGTGAGGAGGGCCGCAGGGAGTACCTGGCGTTT CCCACCAGCAAGAGCTCGGGCCAGAAGGGGCGGAAGGAGCTGCTGAAGGGCAACGGCCGGCGCATCGACTACATGCTGCATGCAGAGGAGGGGCTGTGCCCAGACTGGAAGGCCGAGGTGGAAGAATT CAGTTTTATCACCCAGCTGTCCGGCCTGACGGACCACCTGCCAGTAGCCATGCGACTGATGGTGTCTTCGGGGGAGGAGGAGGCATAGACCGTCCGGAGCAGCGGGGCCTCTGCCAGCCCTTGCAGCT GCAGCCCATCCCTGGGCCATGTCCCCTCCATCGAGTGCCCGGTGCTTGGGGGAGGAGGGCAGGGACAGGGAGGGAGCCACAGTCAGTGCCCGGGAACCTGGAAGCTGCGCTGCTCTGCGCCTCTGGGC CTCACTGTGGACAGAGGAGTCAGGCCCGCCCCAGGAGCCTCCAGCTGCCTAACCAGTGCCATTCTTTCACAACACGATTTTCTACAAATCTACAGCACAACCGAGTTTGTAACCCGTGGGTTAGTATG AGGACCGGGTTCGTGTACTCTCTGTATCTCCTCTTAAGCTTCGTCCAGGGTTCTTTATTTTTGTCTGCTGCCAATGTCGTCTCGCATGCCTGCACCCTCGCATGCACGCTGCCCGCATGCCACGTGCC ACGCTGTAGCCACAGACCCCTTGCTCGGGCCTCACCCAAGGCCAAACTCCAAACACAATCAGAACCAGCCAAAGAAGCACTTCCTGGGCACGGCCACCAGCTCTCCCGCCTCCAGTGTGGGCCGGCTC CTGCAGGGTCCGAGGGCTGCATCTCTACCAGCCAGCCCAGGGCTCTTCCCAGGGTCTCGCATTCAAGGGCAATTACATTTTAAAAAGAAAAACAGAAAAAGGTTAATCACAAAACCAACCCTCACTTC ACAGGGTCTGTAAGTCACTCATAGAACTTTGCTCTTCCCGAGACAGGGTCCCTTCCCCAGCTCAGGCACAACAGAGTCTGGCAGGCTCTGGCACCCTGGGCCTCCTCCGGGAGCCTCCCATCTGGGCA GTGGAGCCATAAACGGGGATCCGAGAAGAGAGTATCCACTTTTTTTTTTACAGGAAGAAGGGACTCACAGCATAAACGGGGGTGGGGGGGATCCTGATTTTGAAAATAATCTATTTGTAGCTTCTCTT CTATCAAAACCAACACATCCTCTTCTTTCTGCCAATCCTCTCCCCCACGGGACACCTCTCTGGTTCGGGACCAATCCCTCCCTGGGGACGTGCCCCACCTGCGTGCCGGCTGAGCTCAGGAACCCCTG CCTGCCCCCCGGGTGGGGCTGCGGCTCTGGCCTCCCAGGCCCATCCTCAACAGCTACCCCAGCCAACACCAAGGCCACAAGGGGACCCCGGCCTAGGAGGCAGGAAGCCAAGGTGCAGAGAGCAGCCT GGCCCTCACCAGTGCGCAAGCTGGGGCAGCAAGGCTGACAGTTGCTGCATGCCCAGGGCAGGGTGTGGTACTGGCACCCAAGTTCAGCATGGCAGAGCTGGCCAACAGCTTGTGGTCCCCGATCTGCC TCCAGCCCCAAGATGCCTACAGCCCCCAGGCCCCTTCGGCAGCACTGCCTCTGCCCACCTGCCTTTAAGAGACTCCAGGGCTGCTCCTGTCATGCAGCGAAGGTTTTGTCTGTTTCAAAGTTCGAGAC TCAACTTGAGGGACTGTTTTTGACAATCCCCGCTGACCTCCGCTCCTCGTGGCGCCCTGGCCCTACACCCAGCCTGGCCCAGGGCCGGCTTTGCCTGGTGAGGCTGGAGGGAGCACCAGGACCTGCTG TCTGCTGTCAGCCCCTCCTGGTGCTGGTGCCCTGATGCTGTGCCTTGTCACCCATTGAGCTGCAAGAGGGACCAAGAGGGGGCCACGCAGCCAGCCAGATGCCTGGCCCTGTGCTGGGGCAGACAACG CTGCAGAGCCCAGGGAGCCTGGCGCTAGGACGTGCGTCCTTGTGACACTGGCCTGTCTGAACTCACCTGGCCTGGGAAGCACCGTCTGCCCGGGCCCAAGCCCTGCCCCTCCAGAGTCCAGAGCCAGG AAGGGGCTGCTGAGGGCGAGCATCCTGCTGGGCTCTCTGCCCGGCCCACCCCTCCAAGGGGCTGGCCTGTGAGCCTTGACTGGGATTCATGATGTGGAGGCCCCCAACTTCCAGAAGCAGCTGGTACT CTGCTCACACAAGCGACTGGGCCGGCCGGCCCTGGACCCCTAGACCCCGAGCCGCCTGCCGACTGCCTGCACAGGGAGAGCAGTTGAGGCCCGGGCAGGGCCCCCACACCAGACCCCAACATAGCTTC CCCACCCAGGCACCCCCTCCCGGGGCAGCAGGCGTGGGAGTCAGGGCTGCATGCTCCTCCCCTCCCACCTCACAGGCGGCCTTAGGCAAGTCATTTTCTGTCATCACAAGGTCGCCTCTGCCTAGTCA GGTCCTGGGGTCCAGAGTAAGGATGTGCGGCCCCCAGGCCCCCGCACACCTCCCTCAGCACCAAGACCGGGACCCCCCCACCCACGTGTCTCATTGTGGCTGCCTATGGACTCCCGGGCCTTGTGTGC AGGCCAGGCCCTTCCACTGATTTTTTAAAGTGAACCATTGCTGGATCTCAGATTCTGTGGCATCTAAGGCCTAGCAGGGGTGGGCACACGGGTCACCCGAGGCCCATACCAAGACTCTGTTCCTGCCC TAGGCCCAGTCTCAAAGGAAGCCACAAGGCGCGGGGGCCACTGAGGAAGGAAATGTTCATTTTCATTTGTCCAAAACCACCTTAAGTTTTAAGTATATTAATCTTGATGCTTTTTAACTATTGCTTTT TAACTTGCTGAGATTTAGAAATACTGTTATAAAAACTTTTTTAATTTCTGTATTTTTTTCTGTATTGTATCTTCATGGGACATTAGGGGTTTTCTATGGTAAGCACACCTATGGTTTTGGTAAAAACA TTATCAAATATATATCCAGACGGTTCTTCCCTAGAAGAAAAACAAGTCTTTACACCTGATAAAATATTTTGCGAAGAGAGGTGTTCTTTTTCCTTACTGGTGCTGAAAGGAAGGATGGATAACGAGGA GAAAATAAAACTGTGAGGCTCAA
hide sequence
RefSeq Acc Id:
XM_005256032 ⟹ XP_005256089
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,386,754 (-) NCBI GRCh37 16 68,392,230 - 68,482,409 (-) NCBI
Sequence:
GGCTGTCAGGTGAGCTCTGGAGATTGTTCCGGGCACCCCTGTGAACTGCTCATCTCCTTTCAGG TCTGCGGTGACAGCTCTTCTTCAGAGAGAAGGACAACAAGGTCCCAGTGGCCCCTCCTCAGGGCTCACTTGGACCCTGTGACCAACCCATACCCTGACCCCTGGCAGAGGTTTCCGGTGGATTTACTT CTCCACGTCTACGGATTTACTGTGCTACCTGTGTCACCAAAGCAACCGCTTCTCTGAGCAGAAAGTTTCTACTACAAATTAAAAGATTAAGACTCAGCTCCCCTGATGCTTCATGGTGCTAGAAGAAC TTGGACAGGGTCTGCAGTAGGCCTCCGCATGGCCCACCGAGGTGAACCATGACCGGCTGGCCAACATTCGCCATTGACCAGCCGGAGTTGCATCTCGCCAGGAGGTGACCCCTCCTCCAGCTGCCCCC AACTCGCCCACCCTCGCCCAGGAAAGTGCCCGCAGCTGCCACGGACACCATGTAGTAGGGCCGGCTGCGGCGCCCAGTGAGCTGCGATGGTTTTGTACACGACCCCCTTTCCTAACAGCTGTCTGTCC GCCCTGCACTGTGTGTCCTGGGCCCTTATCTTTCCATGCTACTGGCTGGTGGACCGGCTCGCTGCCTCCTTCATACCCACCACCTACGAGAAGCGCCAGCGGGCAGACGACCCGTGCTGCCTGCAGCT GCTCTGCACTGCCCTCTTCACGCCCATCTACCTGGCCCTCCTGGTGGCCTCGCTGCCCTTTGCGTTTCTCGGCTTTCTCTTCTGGTCCCCACTGCAGTCGGCCCGCCGGCCCTACATCTATTCACGGC TGGAAGACAAGGGCCTGGCCGGTGGGGCAGCCCTGCTCAGTGAATGGAAGGGCACGGGGCCTGGCAAAAGCTTCTGCTTTGCCACTGCCAACGTCTGCCTCCTGCCCGACTCACTCGCCAGGGTCAAC AACCTTTTTAACACCCAAGCGCGGGCCAAGGAGATCGGGCAGAGAATCCGCAATGGGGCCGCCCGGCCCCAGATCAAAATTTACATCGACTCCCCCACCAATACCTCCATCAGCGCCGCTAGCTTCAG CAGCCTGGTGTCACCACAGGGCGGCGATGGGGTGGCCCGGGCCGTCCCCGGGAGCATTAAGAGGACAGCCTCTGTGGAGTACAAGGGTGACGGTGGGCGGCACCCCGGTGACGAGGCTGCCAACGGCC CAGCCTCTGGGGACCCTGTCGACAGCAGCAGCCCGGAGGATGCCTGCATCGTGCGCATCGGTGGCGAGGAGGGCGGCCGGCCACCTGAAGCTGACGACCCTGTGCCTGGGGGCCAGGCCAGGAACGGA GCTGGCGGGGGCCCAAGGGGCCAGACGCCCAACCATAATCAGCAGGACGGGGATTCAGGGAGCCTGGGCAGCCCCTCGGCCTCCCGGGAGTCCCTGGTGAAGGGGCGAGCTGGGCCAGACACCAGTGC CAGCGGGGAGCCAGGTGCCAACAGCAAGCTCCTGTACAAGGCCTCGGTGGTGAAGAAGGCGGCTGCACGCAGGAGGCGGCACCCCGACGAGGCCTTCGACCATGAGGTCTCCGCCTTCTTCCCCGCCA ACCTGGACTTCCTGTGCCTGCAGGAGGTGTTTGACAAGCGAGCAGCCACCAAATTGAAAGAGCAGCTGCACGGCTACTTCGAGTACATCCTGTACGACGTCGGGGTCTACGGCTGCCAGGGCTGCTGC AGCTTCAAGTGTCTCAACAGCGGCCTCCTCTTTGCCAGCCGCTACCCCATCATGGACGTGGCCTATCACTGTTACCCCAACAAGTGTAACGACGATGCCCTGGCCTCTAAGGGAGCTCTGTTTCTCAA GGTGCAGGTGGGAAGCACACCTCAGGACCAAAGAATCGTCGGGTACATCGCCTGCACACACCTGCATGCCCCGCAAGAGGACAGCGCCATCCGGTGTGGGCAGCTGGACCTGCTTCAGGACTGGCTGG CTGATTTCCGAAAATCTACCTCCTCGTCCAGCGCAGCCAACCCCGAGGAGCTGGTGGCATTTGACGTCGTCTGTGGAGATTTCAACTTTGATAACTGCTCCTCTGACGACAAGCTGGAGCAGCAACAC TCCCTGTTCACCCACTACAGGGACCCCTGCCGCCTGGGGCCTGGTGAGGAGAAGCCGTGGGCCATCGGTACTCTGCTGGACACGAACGGCCTGTACGATGAGGATGTGTGCACCCCCGACAACCTGCA GAAGGTCCTGGAGAGTGAGGAGGGCCGCAGGGAGTACCTGGCGTTTCCCACCAGCAAGAGCTCGGGCCAGAAGGGGCGGAAGGAGCTGCTGAAGGGCAACGGCCGGCGCATCGACTACATGCTGCATG CAGAGGAGGGGCTGTGCCCAGACTGGAAGGCCGAGGTGGAAGAATTCAGTTTTATCACCCAGCTGTCCGGCCTGACGGACCACCTGCCAGTAGCCATGCGACTGATGGTGTCTTCGGGGGAGGAGGAG GCATAGACCGTCCGGAGCAGCGGGGCCTCTGCCAGCCCTTGCAGCTGCAGCCCATCCCTGGGCCATGTCCCCTCCATCGAGTGCCCGGTGCTTGGGGGAGGAGGGCAGGGACAGGGAGGGAGCCACAG TCAGTGCCCGGGAACCTGGAAGCTGCGCTGCTCTGCGCCTCTGGGCCTCACTGTGGACAGAGGAGTCAGGCCCGCCCCAGGAGCCTCCAGCTGCCTAACCAGTGCCATTCTTTCACAACACGATTTTC TACAAATCTACAGCACAACCGAGTTTGTAACCCGTGGGTTAGTATGAGGACCGGGTTCGTGTACTCTCTGTATCTCCTCTTAAGCTTCGTCCAGGGTTCTTTATTTTTGTCTGCTGCCAATGTCGTCT CGCATGCCTGCACCCTCGCATGCACGCTGCCCGCATGCCACGTGCCACGCTGTAGCCACAGACCCCTTGCTCGGGCCTCACCCAAGGCCAAACTCCAAACACAATCAGAACCAGCCAAAGAAGCACTT CCTGGGCACGGCCACCAGCTCTCCCGCCTCCAGTGTGGGCCGGCTCCTGCAGGGTCCGAGGGCTGCATCTCTACCAGCCAGCCCAGGGCTCTTCCCAGGGTCTCGCATTCAAGGGCAATTACATTTTA AAAAGAAAAACAGAAAAAGGTTAATCACAAAACCAACCCTCACTTCACAGGGTCTGTAAGTCACTCATAGAACTTTGCTCTTCCCGAGACAGGGTCCCTTCCCCAGCTCAGGCACAACAGAGTCTGGC AGGCTCTGGCACCCTGGGCCTCCTCCGGGAGCCTCCCATCTGGGCAGTGGAGCCATAAACGGGGATCCGAGAAGAGAGTATCCACTTTTTTTTTTACAGGAAGAAGGGACTCACAGCATAAACGGGGG TGGGGGGGATCCTGATTTTGAAAATAATCTATTTGTAGCTTCTCTTCTATCAAAACCAACACATCCTCTTCTTTCTGCCAATCCTCTCCCCCACGGGACACCTCTCTGGTTCGGGACCAATCCCTCCC TGGGGACGTGCCCCACCTGCGTGCCGGCTGAGCTCAGGAACCCCTGCCTGCCCCCCGGGTGGGGCTGCGGCTCTGGCCTCCCAGGCCCATCCTCAACAGCTACCCCAGCCAACACCAAGGCCACAAGG GGACCCCGGCCTAGGAGGCAGGAAGCCAAGGTGCAGAGAGCAGCCTGGCCCTCACCAGTGCGCAAGCTGGGGCAGCAAGGCTGACAGTTGCTGCATGCCCAGGGCAGGGTGTGGTACTGGCACCCAAG TTCAGCATGGCAGAGCTGGCCAACAGCTTGTGGTCCCCGATCTGCCTCCAGCCCCAAGATGCCTACAGCCCCCAGGCCCCTTCGGCAGCACTGCCTCTGCCCACCTGCCTTTAAGAGACTCCAGGGCT GCTCCTGTCATGCAGCGAAGGTTTTGTCTGTTTCAAAGTTCGAGACTCAACTTGAGGGACTGTTTTTGACAATCCCCGCTGACCTCCGCTCCTCGTGGCGCCCTGGCCCTACACCCAGCCTGGCCCAG GGCCGGCTTTGCCTGGTGAGGCTGGAGGGAGCACCAGGACCTGCTGTCTGCTGTCAGCCCCTCCTGGTGCTGGTGCCCTGATGCTGTGCCTTGTCACCCATTGAGCTGCAAGAGGGACCAAGAGGGGG CCACGCAGCCAGCCAGATGCCTGGCCCTGTGCTGGGGCAGACAACGCTGCAGAGCCCAGGGAGCCTGGCGCTAGGACGTGCGTCCTTGTGACACTGGCCTGTCTGAACTCACCTGGCCTGGGAAGCAC CGTCTGCCCGGGCCCAAGCCCTGCCCCTCCAGAGTCCAGAGCCAGGAAGGGGCTGCTGAGGGCGAGCATCCTGCTGGGCTCTCTGCCCGGCCCACCCCTCCAAGGGGCTGGCCTGTGAGCCTTGACTG GGATTCATGATGTGGAGGCCCCCAACTTCCAGAAGCAGCTGGTACTCTGCTCACACAAGCGACTGGGCCGGCCGGCCCTGGACCCCTAGACCCCGAGCCGCCTGCCGACTGCCTGCACAGGGAGAGCA GTTGAGGCCCGGGCAGGGCCCCCACACCAGACCCCAACATAGCTTCCCCACCCAGGCACCCCCTCCCGGGGCAGCAGGCGTGGGAGTCAGGGCTGCATGCTCCTCCCCTCCCACCTCACAGGCGGCCT TAGGCAAGTCATTTTCTGTCATCACAAGGTCGCCTCTGCCTAGTCAGGTCCTGGGGTCCAGAGTAAGGATGTGCGGCCCCCAGGCCCCCGCACACCTCCCTCAGCACCAAGACCGGGACCCCCCCACC CACGTGTCTCATTGTGGCTGCCTATGGACTCCCGGGCCTTGTGTGCAGGCCAGGCCCTTCCACTGATTTTTTAAAGTGAACCATTGCTGGATCTCAGATTCTGTGGCATCTAAGGCCTAGCAGGGGTG GGCACACGGGTCACCCGAGGCCCATACCAAGACTCTGTTCCTGCCCTAGGCCCAGTCTCAAAGGAAGCCACAAGGCGCGGGGGCCACTGAGGAAGGAAATGTTCATTTTCATTTGTCCAAAACCACCT TAAGTTTTAAGTATATTAATCTTGATGCTTTTTAACTATTGCTTTTTAACTTGCTGAGATTTAGAAATACTGTTATAAAAACTTTTTTAATTTCTGTATTTTTTTCTGTATTGTATCTTCATGGGACA TTAGGGGTTTTCTATGGTAAGCACACCTATGGTTTTGGTAAAAACATTATCAAATATATATCCAGACGGTTCTTCCCTAGAAGAAAAACAAGTCTTTACACCTGATAAAATATTTTGCGAAGAGAGGT GTTCTTTTTCCTTACTGGTGCTGAAAGGAAGGATGGATAACGAGGAGAAAATAAAACTGTGAGGCTCAA
hide sequence
RefSeq Acc Id:
XM_011523207 ⟹ XP_011521509
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,448,508 (-) NCBI
Sequence:
AGATCTGCGGCCGGGAGCCCGGGCTGTGAGGAGCCGGGAGGAGCGGGGTGCGCTGCCGGGCGCTGACCGCCCTCCCGCCCGCCGTCAGAGGTCTGCGGTGACAGCTCTTCTTCAGAGAGAAGGACAAC AAGGTCCCAGTGGCCCCTCCTCAGAGGTTTCCGGTGGATTTACTTCTCCACGTCTACGGATTTACTGTGCTACCTGTGTCACCAAAGCAACCGCTTCTCTGAGCAGAAAGTTTCTACTACAAATTAAA AGATTAAGACTCAGCTCCCCTGATGCTTCATGGTGCTAGAAGAACTTGGACAGGGTCTGCAGTAGGCCTCCGCATGGCCCACCGAGGTGAACCATGACCGGCTGGCCAACATTCGCCATTGACCAGCC GGAGTTGCATCTCGCCAGGAGGTGACCCCTCCTCCAGCTGCCCCCAACTCGCCCACCCTCGCCCAGGAAAGTGCCCGCAGCTGCCACGGACACCATGTAGTAGGGCCGGCTGCGGCGCCCAGTGAGCT GCGATGGTTTTGTACACGACCCCCTTTCCTAACAGCTGTCTGTCCGCCCTGCACTGTGTGTCCTGGGCCCTTATCTTTCCATGCTACTGGCTGGTGGACCGGCTCGCTGCCTCCTTCATACCCACCAC CTACGAGAAGCGCCAGCGGGCAGACGACCCGTGCTGCCTGCAGCTGCTCTGCACTGCCCTCTTCACGCCCATCTACCTGGCCCTCCTGGTGGCCTCGCTGCCCTTTGCGTTTCTCGGCTTTCTCTTCT GGTCCCCACTGCAGTCGGCCCGCCGGCCCTACATCTATTCACGGCTGGAAGACAAGGGCCTGGCCGGTGGGGCAGCCCTGCTCAGTGAATGGAAGGGCACGGGGCCTGGCAAAAGCTTCTGCTTTGCC ACTGCCAACGTCTGCCTCCTGCCCGACTCACTCGCCAGGGTCAACAACCTTTTTAACACCCAAGCGCGGGCCAAGGAGATCGGGCAGAGAATCCGCAATGGGGCCGCCCGGCCCCAGATCAAAATTTA CATCGACTCCCCCACCAATACCTCCATCAGCGCCGCTAGCTTCAGCAGCCTGGTGTCACCACAGGGCGGCGATGGGGTGGCCCGGGCCGTCCCCGGGAGCATTAAGAGGACAGCCTCTGTGGAGTACA AGGGTGACGGTGGGCGGCACCCCGGTGACGAGGCTGCCAACGGCCCAGCCTCTGGGGACCCTGTCGACAGCAGCAGCCCGGAGGATGCCTGCATCGTGCGCATCGGTGGCGAGGAGGGCGGCCGGCCA CCTGAAGCTGACGACCCTGTGCCTGGGGGCCAGGCCAGGAACGGAGCTGGCGGGGGCCCAAGGGGCCAGACGCCCAACCATAATCAGCAGGACGGGGATTCAGGGAGCCTGGGCAGCCCCTCGGCCTC CCGGGAGTCCCTGGTGAAGGGGCGAGCTGGGCCAGACACCAGTGCCAGCGGGGAGCCAGGTGCCAACAGCAAGCTCCTGTACAAGGCCTCGGTGGTGAAGAAGGCGGCTGCACGCAGGAGGCGGCACC CCGACGAGGCCTTCGACCATGAGGTCTCCGCCTTCTTCCCCGCCAACCTGGACTTCCTGTGCCTGCAGGAGGTGTTTGACAAGCGAGCAGCCACCAAATTGAAAGAGCAGCTGCACGGCTACTTCGAG TACATCCTGTACGACGTCGGGGTCTACGGCTGCCAGGGCTGCTGCAGCTTCAAGTGTCTCAACAGCGGCCTCCTCTTTGCCAGCCGCTACCCCATCATGGACGTGGCCTATCACTGTTACCCCAACAA GTGTAACGACGATGCCCTGGCCTCTAAGGGAGCTCTGTTTCTCAAGGTGCAGGTGGGAAGCACACCTCAGGACCAAAGAATCGTCGGGTACATCGCCTGCACACACCTGCATGCCCCGCAAGAGGACA GCGCCATCCGGTGTGGGCAGCTGGACCTGCTTCAGGACTGGCTGGCTGATTTCCGAAAATCTACCTCCTCGTCCAGCGCAGCCAACCCCGAGGAGCTGGTGGCATTTGACGTCGTCTGTGGAGATTTC AACTTTGATAACTGCTCCTCTGACGACAAGCTGGAGCAGCAACACTCCCTGTTCACCCACTACAGGGACCCCTGCCGCCTGGGGCCTGGTGAGGAGAAGCCGTGGGCCATCGGTACTCTGCTGGACAC GAACGGCCTGTACGATGAGGATGTGTGCACCCCCGACAACCTGCAGAAGGTCCTGGAGAGTGAGGAGGGCCGCAGGGAGTACCTGGCGTTTCCCACCAGCAAGAGCTCGGGCCAGAAGGGGCGGAAGG AGCTGCTGAAGGGCAACGGCCGGCGCATCGACTACATGCTGCATGCAGAGGAGGGGCTGTGCCCAGACTGGAAGGCCGAGGTGGAAGAATTCAGTTTTATCACCCAGCTGTCCGGCCTGACGGACCAC CTGCCAGTAGCCATGCGACTGATGGTGTCTTCGGGGGAGGAGGAGGCATAGACCGTCCGGAGCAGCGGGGCCTCTGCCAGCCCTTGCAGCTGCAGCCCATCCCTGGGCCATGTCCCCTCCATCGAGTG CCCGGTGCTTGGGGGAGGAGGGCAGGGACAGGGAGGGAGCCACAGTCAGTGCCCGGGAACCTGGAAGCTGCGCTGCTCTGCGCCTCTGGGCCTCACTGTGGACAGAGGAGTCAGGCCCGCCCCAGGAG CCTCCAGCTGCCTAACCAGTGCCATTCTTTCACAACACGATTTTCTACAAATCTACAGCACAACCGAGTTTGTAACCCGTGGGTTAGTATGAGGACCGGGTTCGTGTACTCTCTGTATCTCCTCTTAA GCTTCGTCCAGGGTTCTTTATTTTTGTCTGCTGCCAATGTCGTCTCGCATGCCTGCACCCTCGCATGCACGCTGCCCGCATGCCACGTGCCACGCTGTAGCCACAGACCCCTTGCTCGGGCCTCACCC AAGGCCAAACTCCAAACACAATCAGAACCAGCCAAAGAAGCACTTCCTGGGCACGGCCACCAGCTCTCCCGCCTCCAGTGTGGGCCGGCTCCTGCAGGGTCCGAGGGCTGCATCTCTACCAGCCAGCC CAGGGCTCTTCCCAGGGTCTCGCATTCAAGGGCAATTACATTTTAAAAAGAAAAACAGAAAAAGGTTAATCACAAAACCAACCCTCACTTCACAGGGTCTGTAAGTCACTCATAGAACTTTGCTCTTC CCGAGACAGGGTCCCTTCCCCAGCTCAGGCACAACAGAGTCTGGCAGGCTCTGGCACCCTGGGCCTCCTCCGGGAGCCTCCCATCTGGGCAGTGGAGCCATAAACGGGGATCCGAGAAGAGAGTATCC ACTTTTTTTTTTACAGGAAGAAGGGACTCACAGCATAAACGGGGGTGGGGGGGATCCTGATTTTGAAAATAATCTATTTGTAGCTTCTCTTCTATCAAAACCAACACATCCTCTTCTTTCTGCCAATC CTCTCCCCCACGGGACACCTCTCTGGTTCGGGACCAATCCCTCCCTGGGGACGTGCCCCACCTGCGTGCCGGCTGAGCTCAGGAACCCCTGCCTGCCCCCCGGGTGGGGCTGCGGCTCTGGCCTCCCA GGCCCATCCTCAACAGCTACCCCAGCCAACACCAAGGCCACAAGGGGACCCCGGCCTAGGAGGCAGGAAGCCAAGGTGCAGAGAGCAGCCTGGCCCTCACCAGTGCGCAAGCTGGGGCAGCAAGGCTG ACAGTTGCTGCATGCCCAGGGCAGGGTGTGGTACTGGCACCCAAGTTCAGCATGGCAGAGCTGGCCAACAGCTTGTGGTCCCCGATCTGCCTCCAGCCCCAAGATGCCTACAGCCCCCAGGCCCCTTC GGCAGCACTGCCTCTGCCCACCTGCCTTTAAGAGACTCCAGGGCTGCTCCTGTCATGCAGCGAAGGTTTTGTCTGTTTCAAAGTTCGAGACTCAACTTGAGGGACTGTTTTTGACAATCCCCGCTGAC CTCCGCTCCTCGTGGCGCCCTGGCCCTACACCCAGCCTGGCCCAGGGCCGGCTTTGCCTGGTGAGGCTGGAGGGAGCACCAGGACCTGCTGTCTGCTGTCAGCCCCTCCTGGTGCTGGTGCCCTGATG CTGTGCCTTGTCACCCATTGAGCTGCAAGAGGGACCAAGAGGGGGCCACGCAGCCAGCCAGATGCCTGGCCCTGTGCTGGGGCAGACAACGCTGCAGAGCCCAGGGAGCCTGGCGCTAGGACGTGCGT CCTTGTGACACTGGCCTGTCTGAACTCACCTGGCCTGGGAAGCACCGTCTGCCCGGGCCCAAGCCCTGCCCCTCCAGAGTCCAGAGCCAGGAAGGGGCTGCTGAGGGCGAGCATCCTGCTGGGCTCTC TGCCCGGCCCACCCCTCCAAGGGGCTGGCCTGTGAGCCTTGACTGGGATTCATGATGTGGAGGCCCCCAACTTCCAGAAGCAGCTGGTACTCTGCTCACACAAGCGACTGGGCCGGCCGGCCCTGGAC CCCTAGACCCCGAGCCGCCTGCCGACTGCCTGCACAGGGAGAGCAGTTGAGGCCCGGGCAGGGCCCCCACACCAGACCCCAACATAGCTTCCCCACCCAGGCACCCCCTCCCGGGGCAGCAGGCGTGG GAGTCAGGGCTGCATGCTCCTCCCCTCCCACCTCACAGGCGGCCTTAGGCAAGTCATTTTCTGTCATCACAAGGTCGCCTCTGCCTAGTCAGGTCCTGGGGTCCAGAGTAAGGATGTGCGGCCCCCAG GCCCCCGCACACCTCCCTCAGCACCAAGACCGGGACCCCCCCACCCACGTGTCTCATTGTGGCTGCCTATGGACTCCCGGGCCTTGTGTGCAGGCCAGGCCCTTCCACTGATTTTTTAAAGTGAACCA TTGCTGGATCTCAGATTCTGTGGCATCTAAGGCCTAGCAGGGGTGGGCACACGGGTCACCCGAGGCCCATACCAAGACTCTGTTCCTGCCCTAGGCCCAGTCTCAAAGGAAGCCACAAGGCGCGGGGG CCACTGAGGAAGGAAATGTTCATTTTCATTTGTCCAAAACCACCTTAAGTTTTAAGTATATTAATCTTGATGCTTTTTAACTATTGCTTTTTAACTTGCTGAGATTTAGAAATACTGTTATAAAAACT TTTTTAATTTCTGTATTTTTTTCTGTATTGTATCTTCATGGGACATTAGGGGTTTTCTATGGTAAGCACACCTATGGTTTTGGTAAAAACATTATCAAATATATATCCAGACGGTTCTTCCCTAGAAG AAAAACAAGTCTTTACACCTGATAAAATATTTTGCGAAGAGAGGTGTTCTTTTTCCTTACTGGTGCTGAAAGGAAGGATGGATAACGAGGAGAAAATAAAACTGTGAGGCTCAA
hide sequence
RefSeq Acc Id:
XM_011523210 ⟹ XP_011521512
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,367,428 - 68,386,754 (-) NCBI
Sequence:
CTGCTCGGTGGCTGTCAGGTGAGCTCTGGAGATTGTTCCGGGCACCCCTGTGAACTGCTCATCTCCTTTCAGGTCTGCGGTGACAGCTCTTCTTCAGAGAGAAGGACAACAAGGTCCCAGTGGCCCCT CCTCAGGGTCTGCAGTAGGCCTCCGCATGGCCCACCGAGGTGAACCATGACCGGCTGGCCAACATTCGCCATTGACCAGCCGGAGTTGCATCTCGCCAGGAGGTGACCCCTCCTCCAGCTGCCCCCAA CTCGCCCACCCTCGCCCAGGAAAGTGCCCGCAGCTGCCACGGACACCATGTAGTAGGGCCGGCTGCGGCGCCCAGTGAGCTGCGATGGTTTTGTACACGACCCCCTTTCCTAACAGCTGTCTGTCCGC CCTGCACTGTGTGTCCTGGGCCCTTATCTTTCCATGCTACTGGCTGGTGGACCGGCTCGCTGCCTCCTTCATACCCACCACCTACGAGAAGCGCCAGCGGGCAGACGACCCGTGCTGCCTGCAGCTGC TCTGCACTGCCCTCTTCACGCCCATCTACCTGGCCCTCCTGGTGGCCTCGCTGCCCTTTGCGTTTCTCGGCTTTCTCTTCTGGTCCCCACTGCAGTCGGCCCGCCGGCCCTACATCTATTCACGGCTG GAAGACAAGGGCCTGGCCGGTGGGGCAGCCCTGCTCAGTGAATGGAAGGGCACGGGGCCTGGCAAAAGCTTCTGCTTTGCCACTGCCAACGTCTGCCTCCTGCCCGACTCACTCGCCAGGGTCAACAA CCTTTTTAACACCCAAGCGCGGGCCAAGGAGATCGGGCAGAGAATCCGCAATGGGGCCGCCCGGCCCCAGATCAAAATTTACATCGACTCCCCCACCAATACCTCCATCAGCGCCGCTAGCTTCAGCA GCCTGGTGTCACCACAGGGCGGCGATGGGGTGGCCCGGGCCGTCCCCGGGAGCATTAAGAGGACAGCCTCTGTGGAGTACAAGGGTGACGGTGGGCGGCACCCCGGTGACGAGGCTGCCAACGGCCCA GCCTCTGGGGACCCTGTCGACAGCAGCAGCCCGGAGGATGCCTGCATCGTGCGCATCGGTGGCGAGGAGGGCGGCCGGCCACCTGAAGCTGACGACCCTGTGCCTGGGGGCCAGGCCAGGAACGGAGC TGGCGGGGGCCCAAGGGGCCAGACGCCCAACCATAATCAGCAGGACGGGGATTCAGGGAGCCTGGGCAGCCCCTCGGCCTCCCGGGAGTCCCTGGTGAAGGGGCGAGCTGGGCCAGACACCAGTGCCA GCGGGGAGCCAGGTGCCAACAGCAAGCTCCTGTACAAGGCCTCGGTGGTGAAGAAGGCGGCTGCACGCAGGAGGCGGCACCCCGACGAGGCCTTCGACCATGAGGTCTCCGCCTTCTTCCCCGCCAAC CTGGACTTCCTGTGCCTGCAGGAGGTGTTTGACAAGCGAGCAGCCACCAAATTGAAAGAGCAGCTGCACGGCTACTTCGAGTACATCCTGTACGACGTCGGGGTCTACGGCTGCCAGGGCTGCTGCAG CTTCAAGTGTCTCAACAGCGGCCTCCTCTTTGCCAGCCGCTACCCCATCATGGACGTGGCCTATCACTGTTACCCCAACAAGTGTAACGACGATGCCCTGGCCTCTAAGGGAGCTCTGTTTCTCAAGT CTTTGCCCGCCAGGACTCAAAGGCACAGCCTTTCGTGTGATTGCTTGTTTTTGCAAGAGAAACACAAGGCTCTGCGGCTCCCAAGGCCACGAGCCAGGAATCAATGAGGCCCAGCAAATAATCAAGTG GATCTTGTGGGTTCTTGTCGTGCAGGGCCCAGTCTGAGGCCTCCCTGCGAGTGTCCAACCCTGTCCGGGACACAGCGCGGGGCAGGTGACACCAAGTGTTGGATGAGTGAGAGGCTGACGCCTTAAGA CCAACAAACAGGCGGCCGGGGAGAAACCGCAAAGACACCAGCCCCTCAGAAAGCAGCGCAGAGCAGCGCACAGCAGCGCACGACAAACA
hide sequence
RefSeq Acc Id:
XM_017023406 ⟹ XP_016878895
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,448,508 (-) NCBI
Sequence:
GTGCGAAACTCCGCCGGTCTCTGGGGGATGTGGTCTTGAAGGAGAGACCCAGGAACCTGCGGGCGGGGCCGGAGGGAGAGGGGAGGACGCCCCCAATGGGCAGACTCCTGGGCGGGGTCCGGGTCACC ATTGGCTCCGGCGGCGCGAGGGAGGCGGGGTCAGAGGAATGAAGCGCGGAGCTGTTCGCCGCTCCAGGTGCTGAGTCTGAGGGAGGCTCCGGACCCGAGAGCCGCGAGAGCCGCCGCCGCTGCGGCCG CCGCCAGATCTGCGGCCGGGAGCCCGGGCTGTGAGGAGCCGGGAGGAGCGGGGTGCGCTGCCGGGCGCTGACCGCCCTCCCGCCCGCCGTCAGAGGTCTGCGGTGACAGCTCTTCTTCAGAGAGAAGG ACAACAAGGTCCCAGTGGCCCCTCCTCAGGGCTCACTTGGACCCTGTGACCAACCCATACCCTGACCCCTGGCAGAGGTTTCCGGTGGATTTACTTCTCCACGTCTACGGATTTACTGTGCTACCTGT GTCACCAAAGCAACCGCTTCTCTGAGCAGAAAGTTTCTACTACAAATTAAAAGATTAAGACTCAGCTCCCCTGATGCTTCATGGTGCTAGAAGAACTTGGACAGGGTCTGCAGTAGGCCTCCGCATGG CCCACCGAGGTGAACCATGACCGGCTGGCCAACATTCGCCATTGACCAGCCGGAGTTGCATCTCGCCAGGAGGTGACCCCTCCTCCAGCTGCCCCCAACTCGCCCACCCTCGCCCAGGAAAGTGCCCG CAGCTGCCACGGACACCATGTAGTAGGGCCGGCTGCGGCGCCCAGTGAGCTGCGATGGTTTTGTACACGACCCCCTTTCCTAACAGCTGTCTGTCCGCCCTGCACTGTGTGTCCTGGGCCCTTATCTT TCCATGCTACTGGCTGGTGGACCGGCTCGCTGCCTCCTTCATACCCACCACCTACGAGAAGCGCCAGCGGGCAGACGACCCGTGCTGCCTGCAGCTGCTCTGCACTGCCCTCTTCACGCCCATCTACC TGGCCCTCCTGGTGGCCTCGCTGCCCTTTGCGTTTCTCGGCTTTCTCTTCTGGTCCCCACTGCAGTCGGCCCGCCGGCCCTACATCTATTCACGGCTGGAAGACAAGGGCCTGGCCGGTGGGGCAGCC CTGCTCAGTGAATGGAAGGGCACGGGGCCTGGCAAAAGCTTCTGCTTTGCCACTGCCAACGTCTGCCTCCTGCCCGACTCACTCGCCAGGGTCAACAACCTTTTTAACACCCAAGCGCGGGCCAAGGA GATCGGGCAGAGAATCCGCAATGGGGCCGCCCGGCCCCAGATCAAAATTTACATCGACTCCCCCACCAATACCTCCATCAGCGCCGCTAGCTTCAGCAGCCTGGTGTCACCACAGGGCGGCGATGGGG TGGCCCGGGCCGTCCCCGGGAGCATTAAGAGGACAGCCTCTGTGGAGTACAAGGGTGACGGTGGGCGGCACCCCGGTGACGAGGCTGCCAACGGCCCAGCCTCTGGGGACCCTGTCGACAGCAGCAGC CCGGAGGATGCCTGCATCGTGCGCATCGGTGGCGAGGAGGGCGGCCGGCCACCTGAAGCTGACGACCCTGTGCCTGGGGGCCAGGCCAGGAACGGAGCTGGCGGGGGCCCAAGGGGCCAGACGCCCAA CCATAATCAGCAGGACGGGGATTCAGGGAGCCTGGGCAGCCCCTCGGCCTCCCGGGAGTCCCTGGTGAAGGGGCGAGCTGGGCCAGACACCAGTGCCAGCGGGGAGCCAGGTGCCAACAGCAAGCTCC TGTACAAGGCCTCGGTGGTGAAGAAGGCGGCTGCACGCAGGAGGCGGCACCCCGACGAGGCCTTCGACCATGAGGTCTCCGCCTTCTTCCCCGCCAACCTGGACTTCCTGTGCCTGCAGGAGGTGTTT GACAAGCGAGCAGCCACCAAATTGAAAGAGCAGCTGCACGGCTACTTCGAGTACATCCTGTACGACGTCGGGGTCTACGGCTGCCAGGGCTGCTGCAGCTTCAAGTGTCTCAACAGCGGCCTCCTCTT TGCCAGCCGCTACCCCATCATGGACGTGGCCTATCACTGTTACCCCAACAAGTGTAACGACGATGCCCTGGCCTCTAAGGGAGCTCTGTTTCTCAAGGTGCAGGTGGGAAGCACACCTCAGGACCAAA GAATCGTCGGGTACATCGCCTGCACACACCTGCATGCCCCGCAAGAGGACAGCGCCATCCGGTGTGGGCAGCTGGACCTGCTTCAGGACTGGCTGGCTGATTTCCGAAAATCTACCTCCTCGTCCAGC GCAGCCAACCCCGAGGAGCTGGTGGCATTTGACGTCGTCTGTGGAGATTTCAACTTTGATAACTGCTCCTCTGACGACAAGCTGGAGCAGCAACACTCCCTGTTCACCCACTACAGGGACCCCTGCCG CCTGGGGCCTGGTGAGGAGAAGCCGTGGGCCATCGGTACTCTGCTGGACACGAACGGCCTGTACGATGAGGATGTGTGCACCCCCGACAACCTGCAGAAGGTCCTGGAGAGTGAGGAGGGCCGCAGGG AGTACCTGGCGTTTCCCACCAGCAAGAGCTCGGGCCAGAAGGGGCGGAAGGAGCTGCTGAAGGGCAACGGCCGGCGCATCGACTACATGCTGCATGCAGAGGAGGGGCTGTGCCCAGACTGGAAGGCC GAGGTGGAAGAATTCAGTTTTATCACCCAGCTGTCCGGCCTGACGGACCACCTGCCAGTAGCCATGCGACTGATGGTGTCTTCGGGGGAGGAGGAGGCATAGACCGTCCGGAGCAGCGGGGCCTCTGC CAGCCCTTGCAGCTGCAGCCCATCCCTGGGCCATGTCCCCTCCATCGAGTGCCCGGTGCTTGGGGGAGGAGGGCAGGGACAGGGAGGGAGCCACAGTCAGTGCCCGGGAACCTGGAAGCTGCGCTGCT CTGCGCCTCTGGGCCTCACTGTGGACAGAGGAGTCAGGCCCGCCCCAGGAGCCTCCAGCTGCCTAACCAGTGCCATTCTTTCACAACACGATTTTCTACAAATCTACAGCACAACCGAGTTTGTAACC CGTGGGTTAGTATGAGGACCGGGTTCGTGTACTCTCTGTATCTCCTCTTAAGCTTCGTCCAGGGTTCTTTATTTTTGTCTGCTGCCAATGTCGTCTCGCATGCCTGCACCCTCGCATGCACGCTGCCC GCATGCCACGTGCCACGCTGTAGCCACAGACCCCTTGCTCGGGCCTCACCCAAGGCCAAACTCCAAACACAATCAGAACCAGCCAAAGAAGCACTTCCTGGGCACGGCCACCAGCTCTCCCGCCTCCA GTGTGGGCCGGCTCCTGCAGGGTCCGAGGGCTGCATCTCTACCAGCCAGCCCAGGGCTCTTCCCAGGGTCTCGCATTCAAGGGCAATTACATTTTAAAAAGAAAAACAGAAAAAGGTTAATCACAAAA CCAACCCTCACTTCACAGGGTCTGTAAGTCACTCATAGAACTTTGCTCTTCCCGAGACAGGGTCCCTTCCCCAGCTCAGGCACAACAGAGTCTGGCAGGCTCTGGCACCCTGGGCCTCCTCCGGGAGC CTCCCATCTGGGCAGTGGAGCCATAAACGGGGATCCGAGAAGAGAGTATCCACTTTTTTTTTTACAGGAAGAAGGGACTCACAGCATAAACGGGGGTGGGGGGGATCCTGATTTTGAAAATAATCTAT TTGTAGCTTCTCTTCTATCAAAACCAACACATCCTCTTCTTTCTGCCAATCCTCTCCCCCACGGGACACCTCTCTGGTTCGGGACCAATCCCTCCCTGGGGACGTGCCCCACCTGCGTGCCGGCTGAG CTCAGGAACCCCTGCCTGCCCCCCGGGTGGGGCTGCGGCTCTGGCCTCCCAGGCCCATCCTCAACAGCTACCCCAGCCAACACCAAGGCCACAAGGGGACCCCGGCCTAGGAGGCAGGAAGCCAAGGT GCAGAGAGCAGCCTGGCCCTCACCAGTGCGCAAGCTGGGGCAGCAAGGCTGACAGTTGCTGCATGCCCAGGGCAGGGTGTGGTACTGGCACCCAAGTTCAGCATGGCAGAGCTGGCCAACAGCTTGTG GTCCCCGATCTGCCTCCAGCCCCAAGATGCCTACAGCCCCCAGGCCCCTTCGGCAGCACTGCCTCTGCCCACCTGCCTTTAAGAGACTCCAGGGCTGCTCCTGTCATGCAGCGAAGGTTTTGTCTGTT TCAAAGTTCGAGACTCAACTTGAGGGACTGTTTTTGACAATCCCCGCTGACCTCCGCTCCTCGTGGCGCCCTGGCCCTACACCCAGCCTGGCCCAGGGCCGGCTTTGCCTGGTGAGGCTGGAGGGAGC ACCAGGACCTGCTGTCTGCTGTCAGCCCCTCCTGGTGCTGGTGCCCTGATGCTGTGCCTTGTCACCCATTGAGCTGCAAGAGGGACCAAGAGGGGGCCACGCAGCCAGCCAGATGCCTGGCCCTGTGC TGGGGCAGACAACGCTGCAGAGCCCAGGGAGCCTGGCGCTAGGACGTGCGTCCTTGTGACACTGGCCTGTCTGAACTCACCTGGCCTGGGAAGCACCGTCTGCCCGGGCCCAAGCCCTGCCCCTCCAG AGTCCAGAGCCAGGAAGGGGCTGCTGAGGGCGAGCATCCTGCTGGGCTCTCTGCCCGGCCCACCCCTCCAAGGGGCTGGCCTGTGAGCCTTGACTGGGATTCATGATGTGGAGGCCCCCAACTTCCAG AAGCAGCTGGTACTCTGCTCACACAAGCGACTGGGCCGGCCGGCCCTGGACCCCTAGACCCCGAGCCGCCTGCCGACTGCCTGCACAGGGAGAGCAGTTGAGGCCCGGGCAGGGCCCCCACACCAGAC CCCAACATAGCTTCCCCACCCAGGCACCCCCTCCCGGGGCAGCAGGCGTGGGAGTCAGGGCTGCATGCTCCTCCCCTCCCACCTCACAGGCGGCCTTAGGCAAGTCATTTTCTGTCATCACAAGGTCG CCTCTGCCTAGTCAGGTCCTGGGGTCCAGAGTAAGGATGTGCGGCCCCCAGGCCCCCGCACACCTCCCTCAGCACCAAGACCGGGACCCCCCCACCCACGTGTCTCATTGTGGCTGCCTATGGACTCC CGGGCCTTGTGTGCAGGCCAGGCCCTTCCACTGATTTTTTAAAGTGAACCATTGCTGGATCTCAGATTCTGTGGCATCTAAGGCCTAGCAGGGGTGGGCACACGGGTCACCCGAGGCCCATACCAAGA CTCTGTTCCTGCCCTAGGCCCAGTCTCAAAGGAAGCCACAAGGCGCGGGGGCCACTGAGGAAGGAAATGTTCATTTTCATTTGTCCAAAACCACCTTAAGTTTTAAGTATATTAATCTTGATGCTTTT TAACTATTGCTTTTTAACTTGCTGAGATTTAGAAATACTGTTATAAAAACTTTTTTAATTTCTGTATTTTTTTCTGTATTGTATCTTCATGGGACATTAGGGGTTTTCTATGGTAAGCACACCTATGG TTTTGGTAAAAACATTATCAAATATATATCCAGACGGTTCTTCCCTAGAAGAAAAACAAGTCTTTACACCTGATAAAATATTTTGCGAAGAGAGGTGTTCTTTTTCCTTACTGGTGCTGAAAGGAAGG ATGGATAACGAGGAGAAAATAAAACTGTGAGGCTCAA
hide sequence
RefSeq Acc Id:
XM_047434336 ⟹ XP_047290292
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,386,754 (-) NCBI
RefSeq Acc Id:
XM_047434337 ⟹ XP_047290293
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,386,754 (-) NCBI
RefSeq Acc Id:
XM_047434338 ⟹ XP_047290294
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,448,508 (-) NCBI
RefSeq Acc Id:
XM_047434339 ⟹ XP_047290295
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,448,508 (-) NCBI
RefSeq Acc Id:
XM_047434340 ⟹ XP_047290296
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,448,508 (-) NCBI
RefSeq Acc Id:
XM_047434341 ⟹ XP_047290297
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,358,327 - 68,381,512 (-) NCBI
RefSeq Acc Id:
XM_054313410 ⟹ XP_054169385
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,154,167 - 74,244,330 (-) NCBI
RefSeq Acc Id:
XM_054313411 ⟹ XP_054169386
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,154,167 - 74,182,680 (-) NCBI
RefSeq Acc Id:
XM_054313412 ⟹ XP_054169387
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,154,167 - 74,244,330 (-) NCBI
RefSeq Acc Id:
XM_054313413 ⟹ XP_054169388
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,154,167 - 74,184,964 (-) NCBI
RefSeq Acc Id:
XM_054313414 ⟹ XP_054169389
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,154,167 - 74,244,330 (-) NCBI
RefSeq Acc Id:
XM_054313415 ⟹ XP_054169390
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,154,167 - 74,244,330 (-) NCBI
RefSeq Acc Id:
XM_054313416 ⟹ XP_054169391
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,154,167 - 74,244,330 (-) NCBI
RefSeq Acc Id:
XM_054313417 ⟹ XP_054169392
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,154,167 - 74,182,513 (-) NCBI
RefSeq Acc Id:
XM_054313418 ⟹ XP_054169393
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,154,167 - 74,193,696 (-) NCBI
RefSeq Acc Id:
XM_054313419 ⟹ XP_054169394
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,162,944 - 74,182,513 (-) NCBI
RefSeq Acc Id:
XM_054313420 ⟹ XP_054169395
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,162,944 - 74,182,513 (-) NCBI
RefSeq Acc Id:
XR_008484705
Type:
NON-CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 16 74,160,852 - 74,182,513 (-) NCBI
RefSeq Acc Id:
XR_933371
Type:
NON-CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 16 68,365,017 - 68,386,754 (-) NCBI
Sequence:
TGCTCGGTGGCTGTCAGGTGAGCTCTGGAGATTGTTCCGGGCACCCCTGTGAACTGCTCATCTC CTTTCAGGTCTGCGGTGACAGCTCTTCTTCAGAGAGAAGGACAACAAGGTCCCAGTGGCCCCTCCTCAGGGTCTGCAGTAGGCCTCCGCATGGCCCACCGAGGTGAACCATGACCGGCTGGCCAACAT TCGCCATTGACCAGCCGGAGTTGCATCTCGCCAGGAGGTGACCCCTCCTCCAGCTGCCCCCAACTCGCCCACCCTCGCCCAGGAAAGTGCCCGCAGCTGCCACGGACACCATGTAGTAGGGCCGGCTG CGGCGCCCAGTGAGCTGCGATGGTTTTGTACACGACCCCCTTTCCTAACAGCTGTCTGTCCGCCCTGCACTGTGTGTCCTGGGCCCTTATCTTTCCATGCTACTGGCTGGTGGACCGGCTCGCTGCCT CCTTCATACCCACCACCTACGAGAAGCGCCAGCGGGCAGACGACCCGTGCTGCCTGCAGCTGCTCTGCACTGCCCTCTTCACGCCCATCTACCTGGCCCTCCTGGTGGCCTCGCTGCCCTTTGCGTTT CTCGGCTTTCTCTTCTGGTCCCCACTGCAGTCGGCCCGCCGGCCCTACATCTATTCACGGCTGGAAGACAAGGGCCTGGCCGGTGGGGCAGCCCTGCTCAGTGAATGGAAGGGCACGGGGCCTGGCAA AAGCTTCTGCTTTGCCACTGCCAACGTCTGCCTCCTGCCCGACTCACTCGCCAGGGTCAACAACCTTTTTAACACCCAAGCGCGGGCCAAGGAGATCGGGCAGAGAATCCGCAATGGGGCCGCCCGGC CCCAGATCAAAATTTACATCGACTCCCCCACCAATACCTCCATCAGCGCCGCTAGCTTCAGCAGCCTGGTGTCACCACAGGGCGGCGATGGGGTGGCCCGGGCCGTCCCCGGGAGCATTAAGAGGACA GCCTCTGTGGAGTACAAGGGTGACGGTGGGCGGCACCCCGGTGACGAGGCTGCCAACGGCCCAGCCTCTGGGGACCCTGTCGACAGCAGCAGCCCGGAGGATGCCTGCATCGTGCGCATCGGTGGCGA GGAGGGCGGCCGGCCACCTGAAGCTGACGACCCTGTGCCTGGGGGCCAGGCCAGGAACGGAGCTGGCGGGGGCCCAAGGGGCCAGACGCCCAACCATAATCAGCAGGACGGGGATTCAGGGAGCCTGG GCAGCCCCTCGGCCTCCCGGGAGTCCCTGGTGAAGGGGCGAGCTGGGCCAGACACCAGTGCCAGCGGGGAGCCAGGTGCCAACAGCAAGCTCCTGTACAAGGCCTCGGTGGTGAAGAAGGCGGCTGCA CGCAGGAGGCGGCACCCCGACGAGGCCTTCGACCATGAGGTCTCCGCCTTCTTCCCCGCCAACCTGGACTTCCTGTGCCTGCAGGAGGTGTTTGACAAGCGAGCAGCCACCAAATTGAAAGAGCAGCT GCACGGCTACTTCGAGTACATCCTGTACGACGTCGGGGTCTACGGCTGCCAGGGCTGCTGCAGCTTCAAGTGTCTCAACAGCGGCCTCCTCTTTGCCAGCCGCTACCCCATCATGGACGTGGCCTATC ACTGTTACCCCAACAAGTGTAACGACGATGCCCTGGCCTCTAAGGGAGCTCTGTTTCTCAAGTCTTTGCCCGCCAGGACTCAAAGGCACAGCCTTTCGTGTGATTGCTTGTTTTTGCAAGAGAAACAC AAGGCTCTGCGGCTCCCAAGGCCACGAGCCAGGAATCAATGAGGCCCAGCAAATAATCAAGTGGATCTTGGTGAGATCACACGGCAGATGAGGAGGGAGAAGCGGGGCGGGAGGGAGCAGGACCTCGT CACTCCTCCGGCCAGTGGGTTCTTGTCGTGCAGGGCCCAGTCTGAGGCCTCCCTGCGAGTGTCCAACCCTGTCCGGGACACAGCGCGGGGCAGGTGACACCAAGTGTTGGATGAGTGAGAGGCTGACG CCTTAAGACCAACAAACAGGCGGCCGGGGAGAAACCGCAAAGACACCAGCCCCTCAGAAAGCAGCGCAGAGCAGCGCACAGCAGCGCACGACAAACAGATCCGACTGGAAGCTGCCTCTTAGACCATG TGAGCCTGTGACCCCGGCCCACAACTCAACTTCTGGCCTCAGTGTGTTCAACGGTGCAGGTGGGAAGCACACCTCAGGACCAAAGAATCGTCGGGTACATCGCCTGCACACACCTGCATGCCCCGCAA G
hide sequence
RefSeq Acc Id:
NP_061137 ⟸ NM_018667
- UniProtKB:
B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), Q9NY59 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
- Sequence:
MVLYTTPFPNSCLSALHCVSWALIFPCYWLVDRLAASFIPTTYEKRQRADDPCCLQLLCTALFTPIYLALLVASLPFAFLGFLFWSPLQSARRPYIYSRLEDKGLAGGAALLSEWKGTGPGKSFCFAT ANVCLLPDSLARVNNLFNTQARAKEIGQRIRNGAARPQIKIYIDSPTNTSISAASFSSLVSPQGGDGVARAVPGSIKRTASVEYKGDGGRHPGDEAANGPASGDPVDSSSPEDACIVRIGGEEGGRPP EADDPVPGGQARNGAGGGPRGQTPNHNQQDGDSGSLGSPSASRESLVKGRAGPDTSASGEPGANSKLLYKASVVKKAAARRRRHPDEAFDHEVSAFFPANLDFLCLQEVFDKRAATKLKEQLHGYFEY ILYDVGVYGCQGCCSFKCLNSGLLFASRYPIMDVAYHCYPNKCNDDALASKGALFLKVQVGSTPQDQRIVGYIACTHLHAPQEDSAIRCGQLDLLQDWLADFRKSTSSSSAANPEELVAFDVVCGDFN FDNCSSDDKLEQQHSLFTHYRDPCRLGPGEEKPWAIGTLLDTNGLYDEDVCTPDNLQKVLESEEGRREYLAFPTSKSSGQKGRKELLKGNGRRIDYMLHAEEGLCPDWKAEVEEFSFITQLSGLTDHL PVAMRLMVSSGEEEA
hide sequence
RefSeq Acc Id:
XP_005256089 ⟸ XM_005256032
- Peptide Label:
isoform X1
- UniProtKB:
B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), Q9NY59 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
- Sequence:
MVLYTTPFPNSCLSALHCVSWALIFPCYWLVDRLAASFIPTTYEKRQRADDPCCLQLLCTALFT PIYLALLVASLPFAFLGFLFWSPLQSARRPYIYSRLEDKGLAGGAALLSEWKGTGPGKSFCFATANVCLLPDSLARVNNLFNTQARAKEIGQRIRNGAARPQIKIYIDSPTNTSISAASFSSLVSPQG GDGVARAVPGSIKRTASVEYKGDGGRHPGDEAANGPASGDPVDSSSPEDACIVRIGGEEGGRPPEADDPVPGGQARNGAGGGPRGQTPNHNQQDGDSGSLGSPSASRESLVKGRAGPDTSASGEPGAN SKLLYKASVVKKAAARRRRHPDEAFDHEVSAFFPANLDFLCLQEVFDKRAATKLKEQLHGYFEYILYDVGVYGCQGCCSFKCLNSGLLFASRYPIMDVAYHCYPNKCNDDALASKGALFLKVQVGSTP QDQRIVGYIACTHLHAPQEDSAIRCGQLDLLQDWLADFRKSTSSSSAANPEELVAFDVVCGDFNFDNCSSDDKLEQQHSLFTHYRDPCRLGPGEEKPWAIGTLLDTNGLYDEDVCTPDNLQKVLESEE GRREYLAFPTSKSSGQKGRKELLKGNGRRIDYMLHAEEGLCPDWKAEVEEFSFITQLSGLTDHLPVAMRLMVSSGEEEA
hide sequence
RefSeq Acc Id:
XP_011521509 ⟸ XM_011523207
- Peptide Label:
isoform X1
- UniProtKB:
B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), Q9NY59 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
- Sequence:
MVLYTTPFPNSCLSALHCVSWALIFPCYWLVDRLAASFIPTTYEKRQRADDPCCLQLLCTALFTPIYLALLVASLPFAFLGFLFWSPLQSARRPYIYSRLEDKGLAGGAALLSEWKGTGPGKSFCFAT ANVCLLPDSLARVNNLFNTQARAKEIGQRIRNGAARPQIKIYIDSPTNTSISAASFSSLVSPQGGDGVARAVPGSIKRTASVEYKGDGGRHPGDEAANGPASGDPVDSSSPEDACIVRIGGEEGGRPP EADDPVPGGQARNGAGGGPRGQTPNHNQQDGDSGSLGSPSASRESLVKGRAGPDTSASGEPGANSKLLYKASVVKKAAARRRRHPDEAFDHEVSAFFPANLDFLCLQEVFDKRAATKLKEQLHGYFEY ILYDVGVYGCQGCCSFKCLNSGLLFASRYPIMDVAYHCYPNKCNDDALASKGALFLKVQVGSTPQDQRIVGYIACTHLHAPQEDSAIRCGQLDLLQDWLADFRKSTSSSSAANPEELVAFDVVCGDFN FDNCSSDDKLEQQHSLFTHYRDPCRLGPGEEKPWAIGTLLDTNGLYDEDVCTPDNLQKVLESEEGRREYLAFPTSKSSGQKGRKELLKGNGRRIDYMLHAEEGLCPDWKAEVEEFSFITQLSGLTDHL PVAMRLMVSSGEEEA
hide sequence
RefSeq Acc Id:
XP_011521512 ⟸ XM_011523210
- Peptide Label:
isoform X2
- Sequence:
MVLYTTPFPNSCLSALHCVSWALIFPCYWLVDRLAASFIPTTYEKRQRADDPCCLQLLCTALFT PIYLALLVASLPFAFLGFLFWSPLQSARRPYIYSRLEDKGLAGGAALLSEWKGTGPGKSFCFATANVCLLPDSLARVNNLFNTQARAKEIGQRIRNGAARPQIKIYIDSPTNTSISAASFSSLVSPQG GDGVARAVPGSIKRTASVEYKGDGGRHPGDEAANGPASGDPVDSSSPEDACIVRIGGEEGGRPPEADDPVPGGQARNGAGGGPRGQTPNHNQQDGDSGSLGSPSASRESLVKGRAGPDTSASGEPGAN SKLLYKASVVKKAAARRRRHPDEAFDHEVSAFFPANLDFLCLQEVFDKRAATKLKEQLHGYFEYILYDVGVYGCQGCCSFKCLNSGLLFASRYPIMDVAYHCYPNKCNDDALASKGALFLKSLPARTQ RHSLSCDCLFLQEKHKALRLPRPRARNQ
hide sequence
RefSeq Acc Id:
XP_016878895 ⟸ XM_017023406
- Peptide Label:
isoform X1
- UniProtKB:
B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), Q9NY59 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
- Sequence:
MVLYTTPFPNSCLSALHCVSWALIFPCYWLVDRLAASFIPTTYEKRQRADDPCCLQLLCTALFT PIYLALLVASLPFAFLGFLFWSPLQSARRPYIYSRLEDKGLAGGAALLSEWKGTGPGKSFCFATANVCLLPDSLARVNNLFNTQARAKEIGQRIRNGAARPQIKIYIDSPTNTSISAASFSSLVSPQG GDGVARAVPGSIKRTASVEYKGDGGRHPGDEAANGPASGDPVDSSSPEDACIVRIGGEEGGRPPEADDPVPGGQARNGAGGGPRGQTPNHNQQDGDSGSLGSPSASRESLVKGRAGPDTSASGEPGAN SKLLYKASVVKKAAARRRRHPDEAFDHEVSAFFPANLDFLCLQEVFDKRAATKLKEQLHGYFEYILYDVGVYGCQGCCSFKCLNSGLLFASRYPIMDVAYHCYPNKCNDDALASKGALFLKVQVGSTP QDQRIVGYIACTHLHAPQEDSAIRCGQLDLLQDWLADFRKSTSSSSAANPEELVAFDVVCGDFNFDNCSSDDKLEQQHSLFTHYRDPCRLGPGEEKPWAIGTLLDTNGLYDEDVCTPDNLQKVLESEE GRREYLAFPTSKSSGQKGRKELLKGNGRRIDYMLHAEEGLCPDWKAEVEEFSFITQLSGLTDHLPVAMRLMVSSGEEEA
hide sequence
Ensembl Acc Id:
ENSP00000219334 ⟸ ENST00000219334
Ensembl Acc Id:
ENSP00000459317 ⟸ ENST00000574662
Ensembl Acc Id:
ENSP00000457236 ⟸ ENST00000561749
Ensembl Acc Id:
ENSP00000455955 ⟸ ENST00000563226
Ensembl Acc Id:
ENSP00000457422 ⟸ ENST00000568373
RefSeq Acc Id:
XP_047290295 ⟸ XM_047434339
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_047290296 ⟸ XM_047434340
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_047290294 ⟸ XM_047434338
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_047290292 ⟸ XM_047434336
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_047290293 ⟸ XM_047434337
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_047290297 ⟸ XM_047434341
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169387 ⟸ XM_054313412
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169390 ⟸ XM_054313415
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169385 ⟸ XM_054313410
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169391 ⟸ XM_054313416
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169389 ⟸ XM_054313414
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169393 ⟸ XM_054313418
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169388 ⟸ XM_054313413
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169386 ⟸ XM_054313411
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169392 ⟸ XM_054313417
- Peptide Label:
isoform X1
- UniProtKB:
Q9NY59 (UniProtKB/Swiss-Prot), B7ZL82 (UniProtKB/Swiss-Prot), Q2M1S8 (UniProtKB/Swiss-Prot), A8K0T6 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054169395 ⟸ XM_054313420
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_054169394 ⟸ XM_054313419
- Peptide Label:
isoform X2
RGD ID: 6793462
Promoter ID: HG_KWN:24096
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_12Hour, Lymphoblastoid
Transcripts: OTTHUMT00000268895
Position: Human Assembly Chr Position (strand) Source Build 36 16 67,039,834 - 67,040,334 (-) MPROMDB
RGD ID: 7232647
Promoter ID: EPDNEW_H22069
Type: initiation region
Name: SMPD3_1
Description: sphingomyelin phosphodiesterase 3
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 16 68,448,506 - 68,448,566 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2015-12-15
SMPD3
sphingomyelin phosphodiesterase 3
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
Symbol and/or name change
5135510
APPROVED